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Regional anaesthetic techniques for the management of post-operative pain 
following total knee arthroplasty (TKA) are becoming increasingly popular. The purpose 
of this randomized control trial was to assess whether periarticular infiltration and 
infusion (LIA and infusion) had a comparable time-to-discharge and analgesic quality to 
a motor-sparing nerve block (MSNB) technique in patients who have undergone TKA. 
The study arms included continuous MSNB (n=35, control) and LIA and infusion (n=35, 
experimental). Continuous anaesthetic infusion of 0.2% Ropivacaine was delivered at a 
rate of 8ml/hr post-operatively. The primary outcome was time to discharge. Secondary 
objectives included pain scores at rest and activity, narcotic consumption, patient 
satisfaction and functional outcomes. Preliminary analysis of 54 patients (MSNB n=29, 
LIA and infusion n=25) was performed. No significant differences in outcome measures 
were demonstrated between groups. Based on these early findings, LIA and infusion 
provides similar clinical and functional outcomes to MSNB following primary TKA. 
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Total knee replacement continues to become a more common surgical treatment 
option for knee arthritis in the Canadian population. Following surgery, a common 
complaint from patients is pain, which can inhibit their ability to mobilise early and delay 
discharge from hospital. Many pain options for pain control are available, each 
possessing their own benefits, but also potential risks. One promising option has been 
the use of local anaesthetic delivered around a nerve or the surgical site to decrease 
pain peripherally. This randomised trail assessed two pain control options using local 
anaesthetic that was constantly delivered either around a nerve or the surgical site to 
prolong the duration of pain control. These two groups were a motor-sparing nerve 
block (control group) and a novel periarticular infusion system (experimental group) that 
was placed in the tissue surrounding the knee joint. We compared the time to 
discharge, pain scores during rest and activity, narcotic medication consumption, and 
patient reported outcomes to assess if our experimental group produced similar 
outcomes to a proven peripheral nerve block following total knee arthroplasty. This 
study’s purpose was to explore a continuous regional anaesthetic technique that was 
provided by a surgeon to circumvent factors such as resource constraints that prohibit 
the widespread use of peripheral nerve blocks in community centres for pain control 
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Chapter 1  
1 Introduction 
The societal demand for total knee arthroplasty (TKA) in Canada is increasing as the 
population ages and average body mass index (BMI) grows, increasing from 55,501 
cases in 2012 to 64,204 in 20161–4. Though TKA has positive long-term functional 
outcomes and improved quality of life, the post-surgical pain associated with the 
procedure can affect patient’s ability to perform physiotherapy effectively and negatively 
affect their post-operative satisfaction5,6. Pain is one of the most common post-operative 
complaints from patients and as it is a subjective experience, it can be challenging to 
anticipate and manage in the early post-operative period. Care-teams regularly rely on 
narcotic analgesics delivered through oral or intravenous patient-controlled analgesia 
(PCA) to reduce patients’ pain, and though these are effective analgesic options, they 
have an undesirable side-effect profile7. These unwanted secondary effects are well 
documented, and range from nausea, sedation, pruritus, and constipation to more 
severe complications like addiction, respiratory depression, and death8. As a result, 
regional analgesic modalities have continued to pique the interest of the surgical 
community as effective alternatives to opioid-based management options. These 
include continuous epidural analgesia (CEA), femoral nerve blocks (FNB) and adductor 
canal block (ACB)/motor-sparing nerve block (MSNB), which have all been found to be 
effective in managing patient’s immediate post-operative pain9–12. They also provide the 
option to deliver anaesthetic agents continuously for a longer analgesic duration, but 
each comes with varying adverse effects and logistical issues. CEA and FNB can cause 
quadriceps weakness and thus delay early mobilization, patient discharge, and increase 
the risk of inpatient falls1013. Motor sparing nerve blocks are increasing in popularity as 
they reduce the impact of most of these issues, but are expensive and require 
dedicated staff and resources, making it a challenge to implement as a standard care 
option in Canadian hospitals14–16.  
Another method that has been adopted in arthroplasty is the use of periarticular 
infiltration analgesia, where local anaesthetic is injected around the joint and incision to 
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provide thorough anaesthetic coverage12,17. Periarticular infiltration reduces the risk of a 
dense motor blockade following surgery and the resources required to provide regional 
blocks12,18,19. It also provides an analgesic quality comparable to that of regional blocks 
following TKA, but does not come without its own compromises19–21. A significant issue 
with periarticular infiltration is the inability to continuously deliver local anaesthetic after 
closure of the surgical incision. A previous study conducted in our center found that 
periarticular infiltration had a shorter analgesic duration compared to that of single-shot 
MSNB technique 12. Without continuous infusion, increased narcotic consumption, 
inability to perform physiotherapy, and an increase in length of stay can occur after the 
duration of effective analgesia has passed.  
We explored the application of periarticular infiltration and infusion, a regional 
anaesthetic method that allows for the continuous delivery of local anaesthetic following 
wound infiltration and closure. A feasible regional technique following TKA needs to 
manage pain to reduce narcotic consumption, be accessible to care providers, is cost-
effective, and not inhibit patients’ ability to ambulate so as to expedite discharge and 
reduce hospital resource utilization. By investigating time to discharge, pain, narcotic 
consumption, physiotherapy progress, and functional outcomes, we intend to determine 
if periarticular infiltration and continuous wound infusion is an effective regional 
anaesthetic alternative and is comparable in terms of analgesic quality and outcomes to 





Chapter 2  
2 Anatomy 
2.1 Anatomy of the Thigh  
2.1.1 Osteology 
The femur makes up the skeletal structure in the thigh of the lower limb and is 
both the strongest and longest bone in the human body. It is part of the appendicular 
skeleton and articulates proximally with the acetabulum of the pelvis through the hip 
joint, a ball and socket type joint. Distally, the femur articulates with the proximal 
tibia through a modified hinge type joint called the tibiofemoral joint, as well as the 
patella through a gliding joint called the patellofemoral joint. Together, these create the 
knee joint. 22 
 
The structure of the femur is unique to suit its function as an essential load bearing 
structure and serves as the origin and insertion for 23 different muscles (figure 1). 
Proximally the major structures include the femoral head, neck, greater trochanter, 
lesser trochanter, intertrochanteric line, and gluteal tuberosity. The femoral head is a 
spheroidal structure that is oriented in an anterosuperiomedial direction off the femoral 
neck. Its smooth surface is only interrupted posteroinferiorly by the fovea, a roughened 
structure that allows for the insertion of the ligamentum teres. It is covered in articular 
cartilage and articulates with the acetabulum to create the hip joint. The femoral neck 
projects from the femur at an average neck-shaft angle of 135 degrees, with an 
anteversion angle of 15-20 degrees. At its base is where the greater and lesser 
trochanters can be found. The greater trochanter is found posterolateral and serves as 
the attachment for multiple muscle groups. Gluteus minimus and gluteus medius insert 
at the greater trochanter to provide the action of hip abduction. The lesser trochanter 
can be found posteroinferiorly at the junction of the femoral shaft and the base of the 
femoral neck and serves as the tendinous insertion point for the iliacus and psoas 
muscles responsible for hip flexion. The intertrochanteric line is a ridge of bone found 
anteriorly on the femur at the junction of the femoral neck and shaft. Structures that 
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attach to it include the lateral border of the hip joint capsule as well as the iliofemoral 
ligament. 22  
 
The diaphysis of the femur is the long, cylindrical shaped portion and has an anterior 
bow with a femoral radius of curvature ranging from 98-120cm in the 
sagittal plane 23. The diaphysis extends distally at an oblique angle to allowing for 
a weight bearing axis that travels through the centre of the femoral head, knee joint 
and ultimately ankle joint. Posteriorly, along its shaft, runs a roughened line called the 
linea aspera, which serves as the insertion point for medial compartment adductors as 
well as the vastus medialis and lateralis, short head of biceps femoris and a portion of 
the gluteus maximus at the gluteal tuberosity of the linea aspera. As the diaphysis 
travels distally, the femoral shaft begins to flare and form the lateral and medial 
condyles that articulate with the proximal tibia as well as the medial and lateral 
epicondyles and adductor tubercle which serve as the attachment points for various 
ligaments and tendons. Between the two condyles you will find the trochlear groove, a 
smooth area that makes up the femoral portion of the patellofemoral joint.  
 
Figure 1: Posterior (A.) and anterior (B.) femoral muscular attachments 




2.1.2 Muscular Compartments:  
The thigh is divided into three osteofascial compartments, called the anterior, posterior 
and medial compartments of the thigh. Two Intermuscular fascial septa extend from the 
fascia lata, the tough deep fascia of the thigh, down to the bone forming the anterior and 
posterior osteofascial compartments. The medial compartment is functionally 
considered its own compartment, as it is not separated by a distinct fascial plane. Figure 
2 demonstrates their various attachments and insertions. 22 
 
2.1.2.1 Anterior Compartment:  
The anterior compartment is most functionally involved with knee joint extension, but 
also hip flexion. The muscles contained in the anterior compartment include sartorius, 
rectus femoris, vastus medialis, vastus medialis obliquus, vastus lateralis, vastus 
intermedius, and articularis genu. The muscles rectus femoris, vastus medialis, vastus 
lateralis, and vastus intermedius are collectively referred to as quadriceps femoris22. 
Table.1 provides information regarding origin, insertion, action, innervation, and 
vascular supply for the anterior compartment muscles.  
Table 1: Anterior compartment muscles 
Muscle Origin Insertion Action Innervation Vascular 
Supply 
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tuberosity, lateral 
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Knee extension Femoral 
Nerve (L2-4) 





















2.1.2.2 Medial Compartment:  
The medial compartment is responsible for adduction across the hip joint, and thus the 
lower leg. Some muscles have multiple compartments, having portions in the medial 
compartment as well as the anterior or posterior compartments. These include adductor 
magnus (medial and posterior compartments), adductor longus (medial and anterior 
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compartments) and pectineus (medial and anterior compartments). Though the medial 
compartment is not defined by intermuscular fascial septae, it is functionally considered 
a separate osteofacial compartment22. Table 2 provides information regarding origin, 
insertion, action, innervation, and vascular supply for the medial compartment muscles.  
Table 2: Medial compartment muscles 
Muscle Origin Insertion Action Innervation Vascular 
Supply 




























































































Within the medial compartment, a triangular shaped canal called the adductor canal is 
formed by the borders of sartorius anteriorly, vastus medialis anterolaterally, and 
posteromedially by adductor longus and magnus (figure 2). Commonly referred to as 
the adductor canal, it is also known as Hunter’s canal or the sub-sartorial canal, and 
contains the femoral artery and vein, descending genicular and muscular branches of 
the femoral artery, the saphenous nerve, and the nerve to vastus medialis prior to its 
insertion into the muscle.  The adductor canal begins at the apex of where the medial 
margins of sartorius and adductor longus meet. Two-thirds of the way down the canal 
the femoral vessels pass posteriorly into the popliteal fossa through the adductor hiatus, 
an tendinous opening in adductor magnus 2224.    
 
 
Figure 2: The borders of the adductor canal 
Reprinted with permission from teachmeanatomy.info 
 
2.1.2.3 Posterior Compartment:  
The posterior compartment of the thigh has the function of knee flexion and hip 
extension and include the following muscles; biceps femoris, semitendinosus, and 
semimembranosus. Collectively known as the hamstring muscles, they span across 
both the knee and hip joints. At the knee, they form the proximal borders of the popliteal 
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fossa, with the biceps femoris laterally and semimembranosus and semitendinosus 
medially. Table 3 provides information regarding origin, insertion, action, innervation, 
and vascular supply for the posterior compartment muscles 
Table 3: Posterior compartment muscles 
Muscle Origin Insertion Action Innervation Vascular 
Supply 





Short head-  
lateral lip of 
linea aspera 





















































2.1.3 Muscle and Cutaneous Innervation: 
The lumbar and sacral plexuses are responsible for providing the lower limb both motor 
and sensory functions through a number of nerve branches. The lumbar plexus leaves 
the spinal canal at vertebral levels L1-L3 and travels deep within the psoas major 
muscle, while the lumbosacral trunk (L4-L5) travels medial on the posterior abdominal 
wall. The sacral plexus (S1-4) travels within the pelvis on the anterior surface of the 
piriformis muscle and external to the pelvic fascia. Together, the lumbosacral trunk and 
sacral plexus form the lumbosacral plexus. These collections of nerve roots form their 
associated branches the more distal they move22. The primary segmental innervation 




Table 4: Segmental innervation and principle nerve roots for hip and knee 
movement 
Movement Muscle Group Nerve Root 
Hip Flexion Iliopsoas Femoral Nerve L1-2 
Hip Extension Gluteus maximus Sciatic Nerve L5-S1 
Hip Abduction Gluteus medius and 
minimus, Tensor Fasciae 
Latae, 
Superior Gluteal Nerve L4-L5 
Hip Adduction Adductors Obturator Nerve L2-3 
Knee Flexion Hamstring Muscles Sciatic Nerve S1 
Knee Extension Quadriceps femoris Femoral Nerve L3-4 
 
2.1.3.1 Lateral Cutaneous Femoral Nerve (L2-3):  
The lateral cutaneous femoral nerve arises at the spinal levels of L2-3. Its route to the 
thigh begins at the lateral boarder of the psoas major muscle, crossing the iliacus 
muscle and entering the leg medial to the anterior superior iliac spine either through or 
posterior to the inguinal ligament. From there, the nerve will variably pass through or 
behind sartorius where two branches arise, the anterior and posterior divisions. The 
anterior supplies sensory innervation to the anterolateral thigh as far as the knee. The 
posterior is responsible for the skin overlying the greater trochanter and may supply 
some of the gluteal area22.  
 
2.1.3.2 Femoral Nerve (L2-4): 
The femoral nerve is primarily responsible for the anterior compartment of the thigh. It 
provides motor innervation for muscles involved in knee extension and hip flexion as 
well as cutaneous sensory branches. It is the largest branch of the lumbar plexus and 
gives innervation to the iliacus and pectineus before dividing into the anterior and 
posterior femoral nerve branches at the level of the lateral femoral circumflex artery. 
The anterior division of the femoral nerve supplies the medial and intermediate 
cutaneous nerves of the thigh (figure 3) as well as the nerve to sartorius. The posterior 
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division contains the motor branches to quadriceps femoris (rectus femoris, vastus 
medialis, vastus medialis obliquus, vastus lateralis, vastus intermedius) as well as the 
largest and longest femoral nerve cutaneous branch, the saphenous nerve. The 
saphenous nerve is responsible for sensation to the medial aspect of the knee as well 
as the lower leg. It descends through the adductor canal and at the distal end gives off 
an infrapatellar branch (contributes to the peripatellar plexus) providing sensation to the 
anteromedial capsule, and patellar tendon. It then pierces the fascia lata between the 
tendons of gracilis and sartorius and continues subcutaneously to supply the prepatellar 
skin and medial lower leg, accompanying the long saphenous vein.  
 
2.1.3.3 Obturator Nerve (L2-4): 
The obturator nerve originates from the lumbar plexus at roots L2-4. It descends within 
the psoas major muscle, passing behind the common iliac vessels, along the lateral wall 
of the pelvis and to the obturator foremen. At the foremen, it divides into the anterior 
and posterior branches, with the anterior providing motor function to adductor longus, 
gracilis, and usually adductor brevis and pectineus as well. It also provides sensory 
input from the hip joint as well as a cutaneous branch that contributes to the subsartorial 
plexus, a network of sensory nerves for the medial aspect of the thigh. The posterior 
branch provides adductor magnus with its motor input as well as adductor brevis (when 
not supplied by the anterior branch). Its terminal branch is the genicular branch of the 
obturator nerve, a sensory filament for the knee joint capsule within the popliteal fossa. 
 
2.1.3.4 Sciatic Nerve (L4-5, S1-3):  
The sciatic nerve is the thickest nerve in the body and has plexus contributions from 
both the lumbosacral trunks (L4-L5) and sacral plexus (S1-3). It exits the pelvis through 
the greater sciatic foramen, below the piriformis muscle, and descends distally deep to 
gluteus maximus along the posterior aspect of the thigh. Along its path, it provides 
sensory branches to the posterior capsule of the hip joint, as well as motor branches to 
the biceps femoris, semitendinosus, semimembranosus, and the ischial origin of 
adductor magnus. Proximal to the knee, it branches into its two largest components, the 
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tibial and common peroneal nerves. Though the level of division is highly variable, it is 
typically described to occur at the junction of the middle and distal thirds of the thigh. 
The tibial nerve is responsible for innervating the deep and superficial posterior 
compartments of the lower leg, and the common peroneal nerve innervates the lateral 
and anterior compartments through its superficial and deep branches respectively22.  
 
2.1.3.5 Posterior Cutaneous Nerve of the Thigh (S1-3):  
The posterior cutaneous nerve stems from the sacral nerve roots S1-3 and leaves the 
pelvis through the greater sciatic foremen. It travels distally beneath the fascia lata in 
the thigh and superficial to the long head of biceps femoris, providing sensory input from 
the gluteal, perineum, and posterior thigh and knee. 
A. B. C.  
Figure 3: The nerves (A.), cutaneous branches (B.) and segmental cutaneous 
distribution (C.) of the lower limb 
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Reprinted with permission from theodora.com/anatomy  
2.2 Arterial Blood Supply:  
The blood supply for the thigh is provided by the femoral artery and its associated 
branches. The femoral artery is a branch of the external iliac artery, and begins at the 
mid-inguinal point, an anatomical landmark found halfway between the pubic symphysis 
and anterior superior iliac spine. It descends through the anteromedial aspect of the 
thigh through the adductor canal and distally goes posterior through the adductor hiatus 
to become the popliteal artery. In the proximal thigh the femoral artery is referred to as 
the common femoral artery and its branches include the superficial epigastric artery, 
superficial circumflex iliac artery, superficial external pudendal artery, deep external 
pudendal artery, and the profunda femoris. Distal to the profunda femoris, the common 
femoral artery becomes the superficial femoral artery and provides muscular branches 
to sartorius, vastus medialis, the adductors, as well as the descending genicular artery 
branch. The profunda femoris supplies the hip joint as well as muscles in all three 
osteofascial compartments. Branches include the lateral and medial circumflex femoral 
arteries, four perforating arteries (terminal profunda is the forth) as well as muscular 
branches to the adductors and posterior compartment muscles22.   
2.3 Anatomy of the Knee Joint:  
2.3.1 Osteology:  
The knee is a modified hinge type synovial joint that has two articulations, the 
tibiofemoral joint and patellofemoral joint. The three bones that make up these joints are 
the femur, tibia, and patella.  
 
The tibiofemoral joint is the articulation point between the distal femur and proximal 
tibia. The joint surfaces are made up of the convex surfaces of medial and lateral 
condyles of the distal femur which are in contact with the articular facets on the medial 
and lateral condyles of the tibial plateau. Their surfaces are covered in a layer of 
articular cartilage to allow smooth, low friction movement25.  
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Distally on the femur, the lateral epicondyle serves as the origin on the lateral collateral 
ligament, while the medial epicondyle is the same for the medial collateral ligament. The 
trochlear groove is a depression anteriorly on the femur that stabilizes the patella in the 
patellofemoral joint during range of motion. Inferiorly and posteriorly is an area called 
the intercondylar fossa where the anterior and posterior cruciate ligaments are found. 
The tibial plateau slopes posteriorly and downwards in relation to the tibial shaft and is 
where the intercondylar eminence or tibial spine is found. Two prominences can be 
found here, the medial and lateral intercondylar tubercles, anterior to which the anterior 
horns of the medial and lateral menisci insert as well as the anterior cruciate ligament. 
Posterior to the tubercles, the posterior horns of the menisci and posterior cruciate 
ligament insert onto the tibia. Inferior to the joint line, and on the anterior aspect of the 
tibia, is where the tibial tuberosity is found and is the insertion point for the patellar 
tendon. Lateral and superior to this area, another prominence called Gerdy’s tubercle 
serves as the insertion site for the Iliotibial tract2225.   
 
The patella is the largest sesamoid bone in the human body and is encapsulated by the 
quadriceps tendon. With flexion and extension, the patella articulates with the distal 
femur in the trochlear groove. Posteriorly on the patella, different areas are in contact 
with the femur during the knee joint’s range of movement. The upper medial and lateral 
facets are in contact with the femur during flexion, the lower medial and lateral facets 




Figure 4: The knee joint 
Reprinted with permission from theodora.com/anatomy  
 
2.3.2 Muscles and Popliteal Fossa:  
The muscles responsible for knee joint movement are found in table 5. 
Table 5: Muscles responsible for knee movement 
Movement Muscles 
Knee Flexion Biceps femoris, semimembranosus, semitendinosus 
(assisted by gracilis, sartorius, gastrocnemius, and plantaris) 
Knee Extension Rectus femoris, vastus lateralis, vastus medialis, vastus 
intermedius 
Medial Rotation (flexed leg) Popliteus, semimembranosus, semitendinosus (assisted by 
sartorius and gracilis) 





A unique muscle to the knee joint is the popliteus. Popliteus is innervated by the tibial 
nerve (L4-5, S1) and forms the floor of the popliteal fossa and is intracapsular, but 
extra-synovial to the knee joint. Its origin is the lateral aspect of the lateral femoral 
condyle and inserts on the posterior surface of the tibia, proximal to the soleus line. Its 
function is to rotate the tibia medially or the femur laterally to unlock a fully extended 
knee at the beginning of flexion22.  
 
Posteriorly, the hamstring and medial and lateral heads of gastrocnemius form the 
borders of the popliteal fossa. The popliteal fossa has a diamond shape, and its borders 
laterally are the biceps femoris proximally and the lateral head of gastrocnemius distally. 
Medially, semimembranosus and semitendinosus are the proximal medial border, while 
the medial head of gastrocnemius makes up the distal medial border. The floor (anterior 
boundary) is made up of the posterior aspect of the femur, the oblique popliteal 
ligament, posterior capsule of the knee joint, and popliteus with its associated overlying 
facia. The roof (posterior boundary) is the popliteal facia. The contents of the popliteal 
fossa include the common peroneal and tibial nerves (most superficial structure), sural 
nerve, short saphenous vein, popliteal lymph nodes, posterior cutaneous nerve of the 
thigh, genicular branch of the obturator nerve, fat, and the popliteal vein and artery 
(deepest structure). 
 
2.3.3 Ligaments:  
There are four major ligaments that stabilize the knee joint in different planes, the 
anterior and posterior cruciate and medial and lateral collateral ligaments. The anterior 
cruciate ligament (ACL) is responsible for restricting anterior movement of the tibia in 
relation to the distal femur. It originates on the posteromedial aspect of the lateral 
femoral condyle and distally inserts anterolaterally to the medial tibial eminence, 
blending with the anterior horn of the lateral meniscus. The posterior cruciate ligament 
(PCL), resists posterior translation of the tibia in relation to the distal femur, and is 
thicker and stronger than the ACL. It originates from the lateral aspect of the medial 
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femoral condyle and extends to the roof of the intercondylar notch. Crossing posterior to 
the ACL, it distally inserts onto the posterior tibia in the intercondylar region22,25.  
 
The medial collateral ligament is attached to the medial epicondyle of the distal femur, 
and resists valgus producing forces on the knee joint. Its deep fibres are attached to the 
medial meniscus and distally inserts onto the medial condyle and body surface of the 
tibia, approximately 2.5cm distal to the condyle. On the lateral aspect of the knee joint, 
the lateral collateral ligament works to resist varus producing forces and is attached to 
the lateral femoral epicondyle. Its insertion distally is on the fibular head, and in contrast 
to the MCL, is not adherent to the lateral meniscus as it descends.  
 
2.3.4 Meniscus:  
The medial and lateral menisci of the knee are fibrocartilaginous structures that 
increase tibiofemoral congruency, act as a secondary stabilizer for the knee joint, 
minimize tibiofemoral contact pressure, and contribute to joint lubrication and articular 
cartilage nutrition 25. These crescent shaped intracapsular structures are poorly 
vascularized and cover approximately two thirds of their associated articular surfaces. 
Each possess an anterior and posterior horn, highly innervated areas compared to the 
rest of the meniscus that provide attachment points centrally on the tibia. The medial 
meniscus is semi-circular in shape and its anterior horn is attached anterior to the 
insertion site of the ACL in the intercondylar area of the tibial plateau. Its posterior horn 
also attaches to the tibia in the intercondylar area, though its insertion is more posterior 
between the insertion of the PCL and the posterior horn of the lateral meniscus. Unlike 
the lateral meniscus, the medial meniscus is also adherent to the joint capsule 
peripherally as was all the deep fibers of the MCL. The shape of the lateral meniscus is 
nearly a full circle, and its anterior horn inserts posterolateral to the ACL insertion and 
its fibers blends into it. The posterior horn insertion is found between the tibial eminence 
and the posterior horn insertion of the medial meniscus and uniquely uses 




2.3.5 Capsule and Synovium: 
The knee joint capsule is a tough fibrous layer surrounds the knee joint. Its 
margins anteriorly include the patella and the patellar tendon. The capsule extends 
posteriorly to the collateral ligaments and distally to the condyles of the tibia. The 
posterior boundaries are the articular margins of the femoral condyles, intercondylar 
notch, and posterior proximal tibia. The synovial membrane is a unique tissue that lies 
deep to the capsule on the knee. Its function is the production of synovial fluid that 
lubricates the tibiofemoral and patellofemoral joints during flexion and extension. Its 
insertion is along the articular margins of the patella, femur and tibia and forms a large 
suprapatellar bursa between the quadriceps tendon and the distal femur22. 
 
2.3.6 Cutaneous and Articular Innervation:  
The peripatellar plexus is a network of nerves responsible for sensation over and 
around the patella. It arises from connections between the infrapatellar branch of the 
saphenous nerve as it travels medial to anterior, medial femoral cutaneous nerve, 
intermediate femoral cutaneous nerve, and the lateral femoral cutaneous nerve. Figure 
5 displays the cutaneous distribution around the knee joint. The Intermediate femoral 
cutaneous nerve provides anterior coverage, the saphenous nerve anteromedial, the 
lateral sural cutaneous nerve laterally and the posterior cutaneous nerve of the thigh for 
sensation posteriorly.  
The articular innervation is through genicular branches from the obturator, femoral, 
tibial, and common peroneal nerves. The posterior aspect is supplied by the genicular 
branch of the obturator nerve, a terminal division of the posterior branch of the obturator 
nerve. The femoral nerve branches to vastus medialis terminate as articular sensory 
branches at the knee joint. The tibial nerve provides genicular branches that run with 
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the medial and middle genicular arteries, and the common peroneal sends branches 
that run with the lateral genicular artery as well as the anterior tibial recurrent artery22. 
 
Figure 5: Knee joint articular innervation from anterior (A.), lateral (B.), and 
posterior (C.) 
Reprinted with permission by 26 Goldman DT, Piechowiak R, Nissman D, Bagla S, 
Isaacson A. Current Concepts and Future Directions of Minimally Invasive Treatment for 
Knee Pain. Curr Rheumatol Rep. 2018;20(9). 
 
2.3.7 Blood Supply: 
The arterial anastomosis surrounding the knee joint receives contribution through 
a number of genicular branches of the popliteal, superficial femoral, lateral circumflex 
femoral, posterior and anterior tibial arteries22. There are superior, middle and inferior 
genicular artery branches arising from each of these larger vessels (figure 6). The 
medial and lateral (deep and superficial) superior genicular branches come from the 
popliteal artery, and curve around the femoral condyles anteriorly to supply the front of 
the knee. The descending genicular artery, a branch of the superficial femoral artery, 
anastomosis with the medial superior genicular artery. Further arterial connections 
occur between the medial superior genicular artery and the inferior medial genicular 
artery as well as the deep branch of the lateral superior genicular artery. The superficial 
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lateral superior genicular artery anastomosis with the descending branch of the lateral 
circumflex femoral artery as well as the inferior lateral genicular artery. The middle 
genicular artery also stems from the popliteal artery and is responsible for the cruciate 
ligament and synovial membrane blood supply. The medial and lateral inferior genicular 
arteries arise from the popliteal artery as well. The lateral inferior genicular 
anastomoses with the lateral superior, medial inferior, anterior and posterior recurrent 
tibial arteries (branches of the anterior tibial artery), and circumflex fibular artery (branch 
of the posterior tibial artery). Together, this complex network of vessels supply the knee 
joint with arterial blood22.  
 
Figure 6: Arterial anastomosis of the knee joint 




Chapter 3  
3 Literature Review 
3.1 Knee Joint Arthritis: 
Arthritis occurs when there is a medical or structural condition that is promoting 
inflammation within the joint. There are over 100 different diseases that cause arthritis 
through a variety of pathophysiologic pathways that lead to localized bone and articular 
cartilage destruction 27. Common etiologies include rheumatoid arthritis, seronegative 
spondyloarthropathies 28, osteoarthritis, and post-traumatic. Though the pathological 
process is different depending on the underlying cause, arthritic diseases share similar 
symptoms and signs including joint pain, joint swelling, erythema, stiffness, loss of 
range of movement, decreased function and significant disability.  
In Canada, arthritis as a whole is the most prevalent chronic health condition that affects 
1 in 5 people over the age of 15, and 1 in 2 seniors over the age of 65 27. It has a female 
predominance with 59.5% of sufferers being women 27. The total economic burden 
arthritis places on the Canadian economy was estimated to be 6.1 billion dollars in the 
year 2000, 33 billion dollars in 2010 and is projected to be 67 billion dollars by 2031. 
This steady rise is  primarily due to the aging population and rising incidence of obesity 
as both are strong risk factors for arthritis29,30. In the knee, the most common arthritic 
conditions are osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis (secondary 
osteoarthritis) 31,32   
  
3.2 Knee Osteoarthritis:  
Also known as degenerative arthritis or degenerative joint disease, osteoarthritis 
(OA) is a condition characterized by articular cartilage deterioration and sclerosis of the 
underlying bone 33,34.  
The knee is the most common site for osteoarthritis followed by the hand and hip 
joints35–37. The age and sex standardized incidence of knee osteoarthritis is 240/100000 
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with the annual incidence in Canada expected to rise from e 30,35,38. Knee OA accounts 
for approximately 80% of the overall osteoarthritis disease burden39. Being the most 
common arthritic condition affecting the knee joint, in 2016, primary total knee 
arthroplasty was performed for a diagnosis of OA in 98.8% (n=46,241) of cases in 
Canada40. Because of this, knee OA carries a significant economic and public health 
burden.  
The exact etiology of osteoarthritis can be difficult to determine, but the overlying 
diagnosis is divided into two separate types, primary and secondary. Primary or 
idiopathic OA is associated with aging and said to have occurred when there is no 
identifiable initiating event or major risk factors such as previous trauma or obesity34,41. 
As articular cartilage ages, imbalances in chondrocyte metabolic pathways and changes 
in the extra-cellular matrix occur as a result of a number of fundamental biologic 
processes42,43. These include increased matrix degradation, reduced matrix repair, 
increased cell death, chondrocyte hypertrophy, calcification and crystallization, 
subchondral sclerosis, osteophyte formation, focal bone remodeling and synovitis 41. 
These age-related changes are responsible for the major pathologic features of OA 
which consist of articular cartilage degradation, ligament and meniscus degradation, 
subchondral sclerosis, osteophyte formation, and joint capsule hypertrophy 41. 
Secondary osteoarthritis occurs as a result of a precipitating factor such as previous 
injury to articular surface, meniscus or ligaments (post-traumatic arthritis), surgery, 
obesity, concomitant rheumatoid arthritis, gout, diabetes, or congenital joint 
abnormalities 38.  
There are two diagnostic definitions for OA, the first being radiographic osteoarthritis. 
The diagnosis of radiographic OA is made with the application of the Kellgren Lawrence 
classification which is a graded assessment of weight bearing films for the radiographic 
features of OA including joint space narrowing, subchondral sclerosis, and deformity of 
bone contour38,44. A Kellgren Lawrence grade of ³ 2 is diagnostic of radiographic OA. 
The second diagnostic definition is symptomatic OA, which is the presence of 
radiographic OA (Kellgren Lawrence grade of ³ 2) as well as symptoms such as pain 
and stiffness in the same knee 45,46. It is important to distinguish the two because 
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symptomatic OA is the more clinically relevant diagnosis as it carries the most 
morbidity, disability, and public health burden 45. In the Johnston County Osteoarthritis 
Project, it was found that though a positive association between the presence of 
radiographic features of OA and patients having pain exists, a large group of patients 
demonstrated radiographic findings that were asymptomatic and not limiting activity (47. 
The Framingham study demonstrated the prevalence of radiographic OA of the knee to 
be 33% (43% women, 31% men) in patients aged 63-94. In this same group, the 
prevalence of symptomatic OA of the knee was only 9.5% (11.4% women, 6.8% men) 
36. The incidence of OA varies due to study population age and disease definition 
utilized 48. Studies that utilize radiographic diagnostic criteria result in a higher incidence 
rate as the severity of radiographic features and disability aren’t strongly correlated 47–50.  
Several risk factors for OA have been identified and include age, female gender, family 
history, obesity, nutrition, previous major or repeated minor trauma or surgery, 
occupational (athletes, laborers), joint malalignment, muscle weakness and sedentary 
lifestyle275145. In a large population-based study, the lifetime risk of developing 
symptomatic knee OA was found to be 44.7% (95% confidence interval [95%CI] 40.0-
49.3%)45. When participants had a history of previous knee trauma or BMI >30, the 
lifetime risk rose to 56% (95% CI, 48.4-65.2) and 60.5% (95%CI, 53.0-58.1) 
respectively, providing proof that these risk factors are particularly important in the 
development of knee OA45.  
3.3 Treatment Options:  
3.3.1 Non-operative treatment:  
Osteoarthritis of the knee can be managed with a variety of conservative and 
pharmacologic options before considering surgery. Typically, these modalities are more 
effective with relieving symptoms in patients who have mild to moderate OA, though 
they should still be considered first-line therapy in all patients regardless of age, 
functional ability, radiographic findings, pain level, and comorbidities 52. Conservative 
management includes the use of exercise, weight loss, knee braces, walking aids, 
transcutaneous electrical nerve stimulation (TENS), local heat, and activity modification. 
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These treatments have been shown to have significant benefit for patients, and are 
often successful with managing mild symptoms, avoiding the use of pharmacologic 
therapy52.  
In terms of pharmacologic management, options that can be utilized in patients with 
moderate to severe symptoms include oral and topical medications as well as 
intraarticular injections.52,53. Non-steroidal anti-inflammatories, selective 
cyclooxygenase-II (Cox-2) inhibitors, acetaminophen, tricyclic antidepressants, and 
selective serotonin and norepinephrine reuptake inhibitors (SNRI) make up the majority 
of oral pharmaceutical options in the management of osteoarthritis. Some oral 
supplements such as glucosamine and chondroitin can be used as well, but the 
evidence is conflicting in regard to their efficacy 52. Opioids should not be routinely 
utilized as they come with a number of side effects such as constipation, nausea, 
sedation, dizziness, dependency, and addiction 52. A large systematic review found only 
a small effect size (standardized mean difference (SMD-0.28, 95% CI, -0.35 to -0.20) of 
non-tramadol narcotics compared to placebo. This corresponds to a 0.7-point difference 
on the visual analogue scale for pain and a number needed to treat to produce one 
additional treatment response of 10 (95% CI, 8-14). This indicates that narcotics are not 
highly effective in the management of pain in OA 54. 
Intraarticular injections consist of three categories; corticosteroids, hyaluronic acid, and 
platelet rich plasma. Their mechanism of action varies, but they all work by reducing 
intraarticular inflammation once administered inside the joint 53. Vannabouathong et al.55 
performed a systematic review of 10 meta-analysis looking at pharmacologic treatments 
for knee osteoarthritis compared to oral placebo. What they found was, after controlling 
for the intraarticular injection placebo effect, high molecular weight hyaluronic acid 
injections (SMD-0.58, 95% CI, 0.36-0.79) provided the most precise treatment effect 
estimate that surpassed their threshold of clinical importance (set at 0.50 standard 
deviation). The treatment with the greatest point estimate of treatment effect was 
platelet rich plasma but was also the least precise (SMD-0.77, 95% CI, -0.29-1.83) 
indicating significant uncertainty in its results 55. In cases of moderate to severe OA 
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where joint symptoms persist despite the compliant use of non-operative treatments, 
referral for surgery is indicated.  
3.3.2 Arthroplasty  
Surgical options for knee arthritis include distal femoral or proximal tibial osteotomies, 
unicompartmental knee arthroplasty, and total knee arthroplasty 56. Total knee 
arthroplasty is the gold standard for patients who have severe OA symptoms and have 
failed all previously tried conservative and medical management strategies 56,57.   
The first iteration of what would become the modern total knee implant was developed 
in 1970 by Peter Walker, John Insall, Chitranjan Ranawat, and Alan Ingis. Named the 
duocondylar knee, it was an anatomic, cemented, partial condylar component that 
preserved both cruciate ligaments. Later it evolved into the duopatellar knee design that 
is more closely related to current implants 58.  Today, primary total knee prostheses are 
comprised of two to four components of varying materials depending on the brand and 
model. They include a distal femoral component, a tibial base plate, tibial tray liner, a 
single tibial tray and liner combination implant, and patella resurfacing implant. The liner 
acts as a low-friction bearing surface for the femoral component to articulate with. 
These implants also adhere to two major design types; fixed-bearing and mobile-
bearing. Though not definitively proven in the literature, mobile-bearing designs allow 
for motion to occur between the tibial tray and liner with the intention of reducing 
component wear, loosening, and subsequent failure by improving range of movement 
59. The procedure involves guided cutting and resection of the articular surfaces of the 
femur and tibia. During this process, the damaged articular cartilage is removed, while 
the surgeon also takes into account final component alignment in the sagittal and 
coronal planes 57. Recent innovations include the use of computer navigation and 
patient specific jigs that intend to decrease error, improve accuracy, and assist in 
difficult primary cases where standard alignment tools can’t be utilized 57,60. Following 
preparation of the femur and tibia, trial components are used to ensure proper 
positioning and sizing of the prosthesis. The final components are then inserted using 
either a press-fit or cemented implant design to maintain the desired alignment and 
restore knee joint kinematics 57. Patients who undergo total knee arthroplasty have 
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successful outcomes with significant improvement in pain and functional limitation 
experiences pre-operatively 5,57,61,62.  
 
3.4 Arthroplasty in Canada:  
The need for total knee arthroplasty in Canada is increasing each year. In the year 
1999, the Canadian Joint Replacement Registry (CJRR) reported that 22,302 total knee 
replacements were performed 63. By 2016, this number had risen to 67,169 procedures, 
a threefold increase in 17 years 40. This trend is also being seen in the United States, 
where the number of total knee arthroplasty procedures is expected to rise by 673% 
from 450,000 in 2005 to 3.48 million in 2030 64. As the societal demand and resource 
utilization for this procedure has increased, our post-operative care has become more 
efficient allowing for patients to be discharged earlier. During that same time period, the 
mean length of stay in hospital shrank from a mean of 8.5 days in 1999 to 3 days by 
2016 indicating our understanding of total knee arthroplasty and its post-operative care 
are evolving40,63.  
 
3.5 Post-operative Pain:  
A common concern shared by patients undergoing total knee arthroplasty is how well 
their post-operative pain will be managed. Poorly managed pain following surgery is an 
important consideration as it can directly affect ambulation, sleep, ability to perform 
physiotherapy and result in prolonged discharge from hospital 65–68.  Factors that are 
associated with an increase in severity of post-operative pain include female gender, 
pain catastrophizing, pre-operative depression, younger age, high pre-operative pain 
level and longer duration of pain 66,69–71. The acute pain following surgery is most severe 
in the early stages, specifically post-operative days one to three, making early 
intervention a priority 65,67. Decreased ambulation and rehabilitation due to poorly 
managed pain can also contribute to complications such as deep vein thrombosis, 
pulmonary embolus, and pneumonia 72. 
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Studies have indicated that poorly managed acute post-operative pain also increases 
the risk of developing chronic pain following total joint arthroplasty 73,74. Baker et al. 5 
demonstrated chronic pain to be a stronger determinant of overall satisfaction, even 
more so than functional impairment, and thus acute pain can have effect on satisfaction 
following TKA 5. Therefore, adequate analgesia is essential to ensure expedited 
discharge, decreased short and long term post-operative complications, and improved 
patient satisfaction. 
 
3.6 Analgesic Medications:  
As pain is a complex and difficult aspect of the post-operative management, healthcare 
professionals utilize a number of analgesic options to decrease the noxious stimuli that 
follow total knee arthroplasty. Nociceptive pain information travels towards the brain 
through afferent sensory nerves when they are stimulated peripherally, and analgesic 
medications work to inhibit this pathway at varying levels. Depending on their 
mechanism, common analgesic medications decrease the intensity of the pain sensory 
pathway by interacting with it at different levels 53. Narcotic medications, or opioids, are 
utilized in the early and most severe stages of pain post-operatively 69,75. They depress 
nociceptor neuron activity through the central activation of opioid receptors, resulting in 
analgesia at the surgical site76. Opioids have traditionally been delivered through 
patient-controlled analgesia, giving patients the choice of when to deliver doses through 
a computerized pump in an attempt to reduce total consumption, and maintain 
satisfaction 77. Though effective, opioids come with host of adverse effects including 
nausea, vomiting, pruritus, urinary retention, constipation, confusion, sedation, and 
more severe complications like respiratory depression, tolerance, addiction, and death 
75,78. Halawi et al. 75 found in a population of 673 total joint arthroplasties, 8.5% of 
patients suffered from a complication as a result of narcotic medication, and these 
events accounted for 58.2% of the total complications in the study. As a result, length of 
stay was significantly prolonged (p<0.001) in patients who suffered from an adverse 
event related to opioids 75. The demand to find effective alternative analgesics has been 
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present for some time now, with studies beginning as far back as 1985 looking at the 
effect of opioids on arthroplasty patients 78.  
A more modern approach to analgesia for arthroplasty patients is the use of multi-modal 
analgesia. Multi-modal analgesia provides a more comprehensive analgesic strategy by 
using multiple drug classes for improved post-operative analgesia, decreased risk of 
major drug related complications, and an expedited discharge can be achieved without 
significant narcotic use 69,77,79. Multi-modal analgesia combines systemic analgesics 
such as non-steroidal anti-inflammatories (NSAIDs), acetaminophen, neuropathic 
medications, and minimal opioid medications with neuraxial and peripheral anaesthetic 
techniques to ensure adequate pain management 79. Lamplot et al. 77 performed a 
randomized controlled trial on patients who had undergone total knee arthroplasty. 
Patient-controlled hydromorphone analgesia served as the control group, where the 
experimental multi-modal group received intra-operative periarticular infiltration with 
bupivacaine, with scheduled post-operative opioids (oxycodone, tramadol) and NSAIDs 
(ketorolac). Total and daily narcotic consumption was found to be significantly lower in 
the multi-modal group (p<0.0004 and p<0.007 respectively). The multimodal group also 
had significantly less narcotic related side effects while in hospital (p<0.01) as well as 
following discharge (p<0.01). They also found a difference in VAS pain scores at rest 
(p<0.0004) and during activity (p<0.001) between groups favoring the multi-modal group 
and that they met physiotherapy milestones faster. As they had only blinded the 
outcomes assessors, a decision was made to end the trial early as there was 
unanimous agreement amongst care providers that multi-modal analgesia was superior 
77.  
3.7 Regional Anaesthesia:  
Regional anaesthetic blocks provide a non-opioid option for post-operative analgesia 
following total knee arthroplasty and promote early ambulation, decrease opioid 
consumption, and as a result, decrease length of stay in hospital 12,80–82. A common 
local anaesthetic that has shown to be a potent analgesic with a favorable safety profile 
is ropivacaine. Ropivacaine is an amino-amide local anaesthetic that blocks nerve fiber 
impulses through reversible inhibition of sodium ion channels, inhibiting afferent 
29 
 
nociceptive information 83. Compared to other local anaesthetics such as bupivacaine, it 
is less lipid soluble, and thus has less risk of central nervous system and cardiac toxicity 
84,85. In the setting of regional anaesthesia, it can be combined with NSAIDs such as 
ketorolac, which inhibits prostaglandin inflammatory mediators, increasing its analgesic 
quality and further reducing opioid consumption 77. Epinephrine can also be added to 
the cocktail to cause localized vasoconstriction, which prolongs the effect of the local 
anaesthetic by having less resorption 17. Andersen et al. 86 compared two different local 
infiltration cocktails, the control being ropivacaine with epinephrine and the experimental 
being ropivacaine, epinephrine with ketorolac. They found that a significant reduction 
(p<0.0001) in morphine consumption at 0 to 48 hours post-op, as well as lower VAS 
pain scores at rest and during movement from 0 to 48 hours post op in the group who 
received ketorolac (p=0.02) 86.  
Regional anaesthetic can be delivered using a number of different techniques described 
in the literature 87,88. In the setting of total knee arthroplasty, common techniques 
include epidural analgesia, femoral nerve blocks, adductor canal block, and periarticular 
infiltration 88. Both peripheral nerve blocks and periarticular infiltration decrease opioid 
consumption, but each have their own benefits and disadvantages 80–82. Peripheral 
nerve blocks are an effective analgesic technique for total knee arthroplasty without the 
side effects associated with systemic or epidural analgesia. Some potential 
complications that can occur with peripheral blocks though include dense motor 
blockade that impairs early ambulation and increases the risk of falling, infection from 
an indwelling catheter, neurologic and vascular injury during the procedure, and 
anaesthetic toxicity 88,89. Periarticular infiltration reduces the risk of motor blockade and 
neurovascular injury while providing excellent analgesia 82. Its relative simplicity and 
reduced procedure time and cost compared to peripheral nerve blocks make it an 
attractive analgesic modality 88. Difficulty with delivering continuous anesthetic to the 
surgical site is a limitation of periarticular infiltration. It relies on diffusion of anaesthetic 
within the tissue surrounding the knee to achieve analgesia, and there is apprehension 
in the surgical community with leaving indwelling catheters due to concerns for 
prosthetic joint infection 69. An issue with the literature comparing regional anaesthetic 
methods is the vast heterogeneity that exists between studies because of variable 
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anaesthetic drug choices, concentrations, doses, infusion rates and assessment 
protocols. Generalizations on efficacy of analgesia, ambulation ability, morphine 
consumption, and complication rates are challenging to make, but consistencies are 
seen between studies.   
 
3.8 Single versus Continuous Regional Anaesthetic:  
Procedural options for regional anaesthesia include single-shot or continuous infusions 
of local anaesthetic through an indwelling catheter depending on the desired duration of 
analgesia and discharge plan 82. The constant administration of local anaesthetic 
around a targeted nerve or the surgical site allows for effective analgesia. The benefit of 
having an indwelling catheter is the ability to administer further doses of anaesthetic to 
prolong the duration of analgesia 81,90–93. Some concerns with continuous blocks and 
catheters though are the increased risk of infection, retained catheter components, 
catheter blockage or dislodgement, and anaesthetic toxicity 81,89,93,94. Current evidence 
has provided little direction for a superior infusion medication, drug concentration, and 
infusion rate for continuous blocks and thus these choices are made by surgeon and 
anesthetist preference, resource availability, and experience 24,88.  
 
3.9 Single-shot Adductor Canal and Motor-sparing Nerve 
Blocks: 
The medial compartment of the thigh contains a triangular shaped canal called the 
adductor canal. The muscular borders of the adductor canal are formed by sartorius 
anteriorly, vastus medialis anterolaterally, and posteromedially by adductor longus and 
magnus 22,24. The contents of the canal include the femoral artery and vein, descending 
genicular and muscular branches of the femoral artery, the saphenous nerve (femoral 
nerve sensory branch), and the nerve to vastus medialis prior to its insertion into the 
muscle 22,24.  First described by van der Wal in 1995, local anaesthetic can be delivered 
here under ultra-sound guidance or through nerve-stimulation to anaesthetize the 
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saphenous nerve and provide a largely isolated sensory block to the anterior aspect of 
the knee 24,95. Adductor canal blocks have gained popularity in recent years due to their 
reduced risk of motor blockade causing quadriceps weakness which can result in 
delayed rehabilitation and discharge in comparison to femoral nerve blocks and epidural 
analgesia 24,87,90,96–98.  
Prior to adductor canal blocks, femoral nerve blocks were a successful peripheral nerve 
block in TKA patients and removed risks like neuraxial haematomas that are associated 
with epidural infusions 87. One of the complications associated with femoral nerve 
blocks is dense motor blockade due to the proximal site of anaesthetic administration 
80,97–99. As adductor canal blocks target saphenous nerve, a sensory branch of the 
femoral nerve, the risk of quadriceps weakness occurring has been shown to be 
significantly reduced while still providing excellent analgesia when compared to femoral 
nerve blocks 24,97–99. Jaeger et al. 99 performed a randomized, double-blinded, and 
placebo controlled cross over study comparing quadriceps strength between adductor 
canal and femoral nerve blocks. Twelve volunteers received an active adductor canal or 
femoral nerve block randomized to either their right or left leg and a placebo in the 
contralateral side. Subjects returned for a second study day to receive the opposing 
active block depending on what they had first. Active peripheral blocks were performed 
using 30 milliliters (ml) of 0.1% ropivacaine, with isotonic saline as the placebo, under 
ultrasound guidance. The primary outcome measure was quadriceps strength 
measured via maximum voluntary isometric contraction (MVIC) in the leg that received 
an adductor canal block versus placebo. Secondary outcomes were the difference in 
quadriceps strength between adductor canal and femoral nerve blocks, difference in 
adductor strength, and mobilization at one and six hours following the procedure (timed 
up and go (TUG), 10-meter walk test and 30-second chair stand test). The investigators 
and subjects were blinded during the study and the study was sufficiently powered 
(power 80%, a=0.05, sample size=10). Baseline quadriceps MVIC measurements were 
taken, and a 25% reduction set as the minimally clinically important difference as a 10% 
difference between subject’s legs is normal. Eleven study subject’s data were analyzed 
finding a significant difference in MVIC between adductor canal and femoral nerve 
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blocks (p=0.002) as well as between placebo and femoral nerve blocks (p=0.0004). The 
mean difference in MVIC in adductor canal blocks was 8% less than baseline, whereas 
in the femoral nerve block group it was 49% less. Adductor strength was significantly 
different (p=0.007) between femoral nerve blocks and placebo, with femoral block 
causing more adduction weakness, but no difference was observed between adductor 
canal and femoral blocks. Regarding the functional tests, subjects demonstrated a 
significant reduction in time to perform both the TUG (p=0.002 at one hour, and p=0.008 
at 6 hours) and 10-m walk tests (p=0.005 at one hour, and p=0.002 at 6 hours) at both 
assessment points with the adductor canal block compared to femoral nerve block. 
Additionally, adductor canal blocks offered a significant advantage over femoral nerve 
blocks in the 30-second chair stand test (p=0.007 at one hour, and p=0.02 at 6 hours). 
The most striking finding in this study was the reduction in quadriceps strength between 
adductor canal and femoral nerve blocks. An 8% reduction wasn’t considered significant 
for the adductor canal block as a 10% difference can exist between subject’s legs 
normally, but a 49% reduction from a femoral block could delay rehabilitation and 
increase fall risk 99.  
These results have been replicated in a number of other randomized controlled trials 
comparing adductor canal and femoral nerve blocks 97,98. Kwofie et al. 98 also performed 
a blinded randomized control trial comparing quadriceps strength between adductor 
canal and femoral nerve blocks. Similarly, their primary outcome was maximum 
voluntary contraction at 30 and 60 minutes following the procedure. Secondary 
outcomes included adduction strength at 30 and 60 minutes as well as Berg Balance 
Scale (BBS) serving as a functional outcome at 30 minutes after the block. The study 
protocol called for participants to receive an adductor canal block in one leg and a 
femoral block on the contralateral side with each block utilizing 15ml of 3% 
chloroprocaine under ultrasound guidance. The study was sufficiently powered with 
sixteen healthy volunteers (power=0.8, a= 0.05, sample size=14) enrolled and a 50% 
difference in quadriceps strength being set as clinically important. MVIC was 
significantly improved with adductor canal blocks, with a mean of 95.1% of MVIC 
preserved compared to only 11.1% in femoral blocks at 30 minutes following the 
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procedure. At 60 minutes, a significant difference was still present, with 98.8% of 
baseline MVIC preserved in with adductor canal blocks and 41.2% in femoral blocks. No 
differences in adduction strength were observed. BBS was significantly impaired in the 
femoral nerve block group (p=0.02) 98.  
Grevstad et al.97 reported similar findings in their 2015 study, where the difference in 
MVIC between adductor canal and femoral nerve blocks was compared in post-
operative patients. Fifty patients were randomized to either adductor canal (n=25) or 
femoral nerve block (n=25) on post-operative day one or two. Patients received both 
procedures and blinding of the care providers was done by having pre-prepared 
containers containing either 30mL of 0.2% ropivacaine or 30mL of saline equally 
distributed between the two blocks. MVIC at 2 hours following the procedure served as 
the primary outcome and was expressed as a percent of the baseline MVIC. The 
secondary outcomes were VAS pain at rest and activity, adductor strength and the TUG 
test for functional assessment at 2 hours post-procedure.  The minimal clinically 
important difference of MVIC between groups was set at 20%, and the study was 
sufficiently powered (power=0.9, a=0.05, sample size=22). Median MVIC significantly 
improved from baseline by 193% (95% CI, 143-288%) following adductor canal block 
versus 16% (95% CI, 3-33%) for femoral blocks, an estimated difference of 178% (95% 
CI, 136-226%, p<0.0001). The TUG test was performed significantly faster in the 
adductor canal block group with a mean difference between groups of 20 seconds (95% 
CI, 9-30s, p=0.001). It was also noted that six of the femoral nerve block patients were 
unable to perform the TUG at 2 hours due to dense motor block of the quadriceps. No 
differences were found in VAS scores at rest and with activity as well as adductor 
strength 97. These studies unfortunately had small sample sizes and failed to compare 
the more clinically relevant outcomes of post-operative pain reduction and function at 
24-48 hours post-op. What they did demonstrate though was the motor protecting 
quality of an adductor block compared to femoral nerve blocks in healthy and post-
operative subjects.  
Studies have shown the analgesic efficacy of adductor canal blocks and femoral nerve 
blocks to be similar. Kuang et al.100 performed a systematic review and meta-analysis of 
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9 recent randomized controlled trials involving 609 patients (668 knees) comparing 
adductor canal and femoral nerve blocks with VAS scores with rest and activity as the 
primary outcome. Secondary outcomes included quadriceps strength (manual muscle 
testing (MMT) and MVIC), opioid consumption, patient satisfaction, and length of stay in 
hospital. The Grading of Recommendations Assessment, Development, and Evaluation 
(GRADE) process was utilized to assess the quality of the evidence for each outcome. 
No significant differences in VAS scores were found at rest at 24 hours (7 studies 
included, p=0.97) and at 48 hours (6 studies included, p=0.23). With activity, no 
significant differences were found between groups at 24 hours (7 studies included, 
p=0.30) and 48 hours (7 studies included, p=0.18). Quadriceps strength between 
groups was significantly different, favoring the adductor canal block group at 24 hours 
(p=0.002) with MVIC, and at 8 (p=0.04), 24 (p=0.03) and 48 hours (p=0.04) with MMT. 
No other secondary outcomes were found to be significant between groups 100. They 
concluded that adductor canal blocks can provide similar analgesia to femoral blocks, 
while avoiding mobility issues due to quadriceps weakness, and recommended its use 
in the total knee arthroplasty population.  
The knee joint is innervated by the femoral and obturator nerves anterolaterally and 
sciatic nerve posteriorly. A motor-sparing nerve block (MSNB) includes an additional 
two single-shot injections in the posterior pericapsular area and around the lateral 
cutaneous nerve of the thigh to provide more anaesthetic coverage than a standard 
adductor canal block 12. Our centre previously performed a randomized controlled trial 
comparing motor sparing nerve block and periarticular infiltration. Sogbein et al. 12 
randomized 82 primary TKA patients to receive either a motor- sparing nerve block 
(experimental, n = 41) or periarticular infiltration (control, n = 41) to compare between-
group duration of analgesia. Patients were enrolled between July 2014 and June 2015 
and randomization was stratified by age and surgeon to ensure that the groups were 
balanced with respect to these factors. The primary outcome measurement was 
analgesic duration, measured as time from end of MSNB/Infiltration administration to 
end of effective analgesia (i.e. pain score at rest/activity >6 on the 11-point NRS and 
initiation of rescue analgesia). Secondary outcomes included quadriceps strength 
(MVIC), TUG test, patient reported outcome data (Western Ontario and McMaster 
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University Osteoarthritis Index, Short-Form-12 Survey, and Knee Society Score), 
narcotic consumption and side effects, and length of stay. Both the motor-sparing nerve 
block and infiltration groups received a drug cocktail of 0.5% ropivacaine, 2.5mcg/mL 
epinephrine, 10mg of morphine, and 30mg of ketorolac. The motor-sparing nerve block 
consisted of a posterior knee infiltration injection of 20mL, a lateral cutaneous nerve of 
the thigh block with 5mL, an intermediate cutaneous nerve of the thigh block delivered 
under the fascia lata at mid-thigh of 10mL and finally, the adductor canal was injected 
with 25mL for a total of 60mL. Intraoperatively, the periarticular infiltration group was 
infiltrated with 100mL of the study drug.  Randomization was performed by research 
assistants not involved in the study, while the patients, surgeons, anaesthetists, and 
outcome assessors were all blinded to avoid selection, performance, and detection 
biases. Patients were analyzed on an intention-to- treat basis, using ANCOVA to 
compare outcomes and a post-hoc Bonferroni correction to adjust for multiple 
comparisons error. The study was sufficiently powered and used an equality sample-
size calculation to detect the minimal clinically important difference (power=0.8, 
a=0.05). MSNB provided significantly longer duration of analgesic effect, with a mean 
difference of 8.8 hours (95% CI= 3.98-13.62 hours, p<0.01) compared to periarticular 
infiltration. MSNB also had statistically significant lower pain scores at 2- and 4-hours 
post-op with activity, and 2 hours post-op at rest. All other time points and secondary 
outcomes did not show significant differences. The results provided evidence that 
MSNB is a suitable technique for pain management following TKA 12. This study was 
considered part-one of a two-part regional anaesthetic trial and the methodology and 
results framed what would become the current study.  
 
3.10 Local Wound Infiltration:      
In 2008, Kerr and Kohan first described in a non-randomized case series a multi-modal 
anaesthetic technique they coined local infiltration analgesia (LIA), also known as 
periarticular infiltration 101. Though wound infiltration with anaesthetic was not a new 
concept, the use of large volumes combined with specific injection placement hadn’t 
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been described in the literature previously. The tissues surrounding the knee including 
the posterior joint capsule (30-50mL), lateral and medial joint tissue (30-50mL) as well 
as the anterior wound edges (25-50mL) were systematically infiltrated with a total of 
150-170mL of the study drug (0.2% ropivacaine, 10mcg/mL epinephrine, and 30mg 
ketorolac) to provide complete anaesthetic coverage. An intra-articular catheter was 
placed for bolus injections at the end of the surgical case. Their results were positive, 
with 71% of patients being discharged post-op day 1 and no serious adverse effects 
noted throughout the trial period 101. Similar to peripheral nerve blocks, LIA has 
demonstrated a number of benefits over previous analgesic techniques. LIA has been 
shown to decrease post-operative pain scores, decrease narcotic consumption, improve 
early function and ambulation, and have less risk of complications associated with some 
other regional anaesthetic procedures 17,77,81,82,88,101,102. 
Busch et al. 17 performed a randomized controlled trial of 64 TKA patients comparing 
LIA (n=32) to no injection (n=32). Patients were blinded as to what group they were 
randomized to and the experimental injection consisted of a 100mL mixture of 400mg 
ropivacaine, 30mg ketorolac, 5mg of epimorphine, and 0.6mL of epinephrine. Narcotic 
consumption in the first 24 hours served as the primary outcome, with secondary 
outcomes including VAS scores for pain and satisfaction, patient reported outcomes 
(WOMAC, KSS), length of stay, and complications. Five patients had serum ropivacaine 
levels drawn at 30 minutes, 1 hour, and 4 hours post-op and all patients underwent a 
post-operative lower limb ultrasound for deep vein thrombosis (DVT) at post-op day 5. 
In the infiltration group, narcotic consumption through PCA was significantly less at 6 
hours (p<0.01),12 hours (p=0.016), and overall at 24 hours post-op (p<0.001). VAS pain 
scores were significantly less in the post-anaesthetic care unit (PACU) (p=0.04) as well 
as 4 hours post-op (p=0.007). Satisfaction scores were significantly higher in the LIA 
group in PACU (p=0.016) and four hours post-op (p=0.016). None of the experimental 
patients demonstrated toxic levels of serum ropivacaine, with the highest level being 2.5 
times less than the level of toxicity, and one patient suffered a DVT in the infiltration 
group. No other significant differences were present between groups. In conclusion, 
they recommended the use of LIA in patients undergoing total knee arthroplasty as it 
decreased narcotic consumption and improved pain scores and satisfaction 17. The 
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results of this study were supported in a recent systematic review and meta-analysis of 
38 RCTs by Seangleuluret al. 103 where LIA had significantly decreased VAS rest pain 
scores at 24 hours post-op versus placebo or no injection after sensitivity analysis was 
performed to remove narcotic and NSAIDs as potential confounders (n=24 studies). 
Narcotic consumption at 24 (n=20 studies) and 48 hours (n= 10 studies) was also 
significantly reduced in the LIA group compared to placebo or no injection.  LIA patients 
also had a shorter length of stay in hospital compared to controls (n=9 studies) 103. 
Similar to adductor canal blocks, periarticular infiltration shares the benefit of sparing 
motor function to the quadriceps muscles, resulting in less risk of weakness and 
delayed rehabilitation. Li et al. 104 randomized 82 patients into three different groups, 
LIA (n=26), adductor canal block (n=26), and femoral nerve block (n=29) to compare 
numerical rating score (NRS) pain scores at rest and activity at 2, 6, 12, 24, 36, 48, and 
72 hours post-op. Secondary outcomes included quadriceps and adductor strength at 
the same time intervals using MMT, knee range of movement, TUG test, as well as total 
daily ambulation. The peripheral nerve blocks were performed under ultrasound with 
20mL 5g/L ropivacaine and 0.1mg adrenaline, and periarticular infiltration was with 
90mL total of 2.5g/L ropivacaine and 0.1mg adrenaline injected throughout the joint. 
Final analysis included 77 patients and revealed that LIA had significant lower NRS 
scores than the nerve block groups at rest at 2, 6, and 12 hours post-op (p<0.05). No 
differences were present at any other time points or during activity at any time points 
between groups. The LIA group had significantly less total narcotic consumption when 
compared to the nerve block groups (p<0.05). Quadriceps weakness was significantly 
increased in the femoral nerve block group within the first 12 hours, but not after 
(p<0.05). A significant difference in TUG test and daily ambulation distance was also 
present, favoring LIA on post-op day one over both nerve block groups (p<0.05), and 
was only significantly different from femoral nerve blocks on post-op day two (p<0.05). 
The length of stay for the LIA group was significant as well, demonstrating a shorter 
inpatient period compared to the nerve block groups (p<0.05) 104. This was a small 
study, with little information being provided in regard to their power calculation, and it 
likely was underpowered to make any definitive conclusions.  
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A recent meta-analysis of 14 trials, including 1122 patients comparing LIA with femoral 
nerve blocks contradicted these results, finding no statistically significant differences 
between groups regarding narcotic consumption, pain scores at rest and activity, 
functional outcomes and complications. They warned readers though to interpret the 
results with caution as significant heterogeneity between studies existed and no firm 
conclusions could be made 20. 
Sardana et al. 105 reviewed the literature and compared LIA analgesia with adductor 
canal blocks following total knee arthroplasty. They conducted a meta-analysis including 
6 studies of 396 patients that had a high amount of agreement among quality 
assessment scores using the Jadad scale. Quantitative analysis revealed the VAS pain 
scores for the LIA group were significantly reduced (p=0.001) compared to adductor 
canal blocks.  A similar result was found when comparing the narcotic consumption, 
with LIA have significantly less (p=0.03). Unfortunately, functional outcomes were not 
able to be analyzed due to the significant heterogeneity between studies. They 
concluded that LIA has the potential to improve post-operative pain and reduce narcotic 
consumption compared to adductor canal blocks but could not make any definitive 
conclusions, stating more literature is needed 105.  
One of the limitations of LIA is the short duration of effective analgesia, ranging from 8-
48 hours, and the challenge of developing a reliable method of continuous deliver 
anaesthetic post-operatively 81,105. Numerous studies have been performed exploring 
the idea using different medications, drug concentrations, and infusion rates with 
variable results 106–110 
 
3.11 Continuous Epidurals Analgesia: 
Continuous epidural analgesia involves the placement of am indwelling catheter into the 
epidural space to prolong the analgesic effect similar to peripheral nerve blocks. Prior to 
the wide spread use of peripheral nerve blocks, neuraxial anaesthesia was a successful 
regional analgesic option in orthopaedic surgery. Epidural analgesia has fallen out of 
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favor though due to its tendency to cause concomitant motor block and concerns over 
its safety profile 111,112. Neuraxial haematoma is a risk following epidural and is 
increased in orthopaedic patients (1:4000) compared to other surgical procedures 
(1:10000-20000). The reason for this is the use of early anti-coagulation in this patient 
population due to the increased risk of venous thromboembolism 87,111. Gerrard et al. 96 
performed a meta-analysis of 12 randomized trials comparing peripheral nerve blocks to 
epidural analgesia and found that there were no statistically significant differences in 
VAS pain scores a 0-12, 12-24, and 24-48 hours post-op between the two groups. What 
was found was that epidurals significantly increased the risk of post-operative 
complications including nausea and vomiting (p=0.002), hypotension (p=0.0009), and 
urinary retention (p<0.0001) 96. Peripheral nerve blocks provide the same analgesic 
benefit of epidural analgesia with less risk of complications 112.  
 
3.12 Continuous femoral nerve blocks:  
Femoral nerve blocks are a common regional anaesthetic technique due to their low 
procedural difficulty and success with lower limb analgesia 113. First described by Labat 
in 1920, they have risen in popularity in the last few decades in the orthopaedic 
community 113–115. Local anaesthetic can be delivered through a single-shot or through a 
perineural catheter to prolong the analgesic effect 80,113. 
Chan et.al.113 randomized 200 patients prior to undergoing total knee arthroplasty to 
three treatment options, Intravenous PCA (1mg morphine, 10mg/hr lockout), single-
injection femoral nerve block (20mL 0.25% bupivacaine with 2.5mcg/mL adrenaline), 
and continuous femoral nerve block (20mL 0.25% bupivacaine with 2.5mcg/mL 
adrenaline injection, followed by 0.125% bupivacaine 4mL/hr infusion). The primary 
outcome for the study was significant pain with activity, defined as a VAS pain score of 
greater than 4. Secondary outcomes included VAS pain score at rest, cumulative 
narcotic consumption, side effects such as nausea and vomiting, number of days to 
achieve 90 degrees of flexion range of motion, and complications. The study was 
sufficiently powered, with a sample size of 60 (power=0.8, a=0.05) being calculated for 
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the primary outcome. At the time of analysis, 64 patients were in the PCA group, 68 in 
the single-injection group and 65 in the continuous infusion. Compared to PCA, the 
proportion of patients who suffered from significant pain (VAS>4) was found to be 
significantly lower in both the single-injection femoral block (OR 0.36; 95% CI 0.15 – 
0.86; p=0.022) and continuous groups (OR 0.25; 95% CI 0.11 – 0.6; p=0.002). VAS 
pain scores at rest were significantly lower in the continuous femoral block at 6 hours 
post-op compared to PCA (p=0.018). VAS pain score with activity was found to be 
significantly lower in both the single-injection group (p=0.045) and continuous femoral 
nerve block group (p<0.0001) compared to PCA at 24 hours post-op. A significant 
difference was also found at 24 hours between the two peripheral block interventions, 
favoring the continuous nerve block (p=0.045), indicating the duration of effective 
analgesia for the single-injection had passed. Both groups had significantly lower 
cumulative narcotic consumption compared to PCA, and continuous peripheral nerve 
blocks had significantly lower consumption than single-injection on post-op day 1 
(p<0.001) and 2 (p<0.001). Regarding time to reach 90 degrees of flexion, both single- 
injection (2.3 days, p=0.014) and continuous nerve block (2.4 days, p=0.024) groups 
reached it significantly earlier than PCA (3 days). Nausea and vomiting were 
significantly less evident in the nerve block groups, and no adverse events occurred 
during the study period. They concluded that femoral nerve blocks provided superior 
analgesia over PCA, with possible additional benefits of decreased narcotic 
consumption, earlier functional recovery, and less side effects. Unfortunately, there was 
no blinding at any level (patient, provide, or outcome assessor) during the study and 
they recognized that small treatment benefit differences between single and continuous 
femoral nerve blocks could not be found as their study wasn’t sufficiently powered to do 
so 113.  
Certain complications are a major concern with femoral nerve blocks. Feibel et al. 13 
performed a retrospective review of patients who underwent total knee arthroplasty and 
received a femoral nerve perineural catheter. Two groups of patients were established, 
a group of 469 patients who had a femoral block infusion for 2-3 days post-op and 
another 721 patients whose infusion was discontinued 12 hours post-op. In the 469-
patient group, 0.4% (n=2) suffered a nerve palsy, and 0.85% (n=4) sustained a fall due 
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to motor weakness while in the 721-patient group, nerve palsies occurred in 1% (n=7), 
with 0.2% (n=2) being permanent, and 0.55% (n=4) of patients had a fall. The overall 
incidence of neurologic injury was found to be 0.6% in this study but has been quoted to 
be as high as 1.2% following TKA 13,116. Though rare, neurologic injury possess a 
potentially catastrophic outcome in TKA patients and patients should be cautioned. 
Transient motor weakness is also an issue with femoral nerve blocks 89,90,93,113. The 
rectus femoris, a major contributor to active knee extension, receives motor function 
from two nerve branches of the femoral nerve. An anatomical study with cadaveric 
specimens found the proximal and distal motor branches to rectus femoris can be found 
8±2.12cm and 17.25±5.21cm distal to the femoral nerve at the inguinal ligament 
respectively 117.  The insertion site for the femoral block is proximal to both of these 
motor branches and thus explains why quadriceps motor function can be compromised 
following a femoral block 80,97–99. As a result of this, along with the success of adductor 
blocks and Infiltration for analgesia, femoral nerve blocks have become a less attractive 
option in modern arthroplasty care 114.  
 
3.13 Continuous adductor canal blocks:  
Similar to femoral nerve blocks, adductor canal blocks offer the option of adding a 
perineural catheter to extend the duration of analgesia past what single-injection 
techniques can provide 80. The benefit of adductor canal blocks compared to femoral 
nerve blocks and epidural analgesia is the decreased risk of quadriceps weakness 
which can limit rehabilitation and delay discharge 80,118,119.   
Shah et al. 91 performed a randomized control trial comparing single-injection versus 
continuous adductor canal blocks.  The sample included 46 continuous and 39 single-
injection participants and was sufficiently powered to detect a clinically significant 
difference of 10mm in VAS score (power=0.8, a=0.05, sample size=44). The single-
injection consisted of 30cc 0.75% ropivacaine injection, followed by repeated 30cc 
saline boluses every 4 hours post-op. The continuous adductor canal block group 
received a 30cc 0.75% ropivacaine injection as well, but a 30cc 0.25% ropivacaine 
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bolus was delivered every 4 hours post-op. The primary outcome was VAS pain score 
at 4, 8, 12, and 24 hours post-op, with secondary outcomes including TUG test, 10-m 
walk test, 30s chair test, ambulation distance at discharge, maximum knee flexion at 
discharge, and length of stay. They found that the continuous group had statistically 
significant lower VAS pain scores at rest and during activity at 4, 8 ,12, and 24 hours 
post op (p<0.001). There was also a significant difference in pain scores favoring the 
continuous block group at rest and activity on post-op day 1 and 2 (p<0.001, p<0.001). 
The timed up and go, 10-m walk, and 30s chair tests were used to assess ambulation 
ability and though the continuous group had faster times, they were not significant. 
Functional recovery outcomes (staircase competency, walker ambulation, ambulation 
distance, flexion range at discharge) demonstrated no significant differences. Two 
patients in the single-injection group required rescue opioid analgesia and none in the 
continuous group, which was consistent with other studies. No other secondary 
outcomes were found to have significant differences. They concluded at the end of this 
study that adductor canal blocks provide excellent analgesia following TKA, with 
continuous adductor canal blocks demonstrating superior analgesia over single-injection 
91.  
One would expect this outcome, as intuitively, having the ability to deliver more 
anaesthetic over time should yield a longer duration of analgesia. However, the results 
comparing single-shot and continuous adductor canal blocks have been inconsistent. 
Zhang et al. 120 performed a randomized, placebo-controlled trial comparing single-shot 
adductor canal block, continuous adductor canal block and a saline control group (Y 
zhang, ultrasound). The single-injection consisted of an ultrasound guided 20mL 0.5% 
ropivacaine pre-operatively followed by two 20mL saline boluses at 12- and 24-hours 
post-op. The continuous group received the same pre-operative regimen, with 20mLof 
0.5% ropivacaine given at 12 and 24 hours, and the saline control group received saline 
for all three injections. The primary outcome was visual analogue scale for pain during 
activity, with secondary outcomes including opioid consumption, quadriceps strength, 
range of motion, procedural time and complications. The results showed no differences 
in any outcome measures except procedural time (single-injection; 4 ± 1.4 minutes 
versus continuous; 20 ± 5.0 minutes) when comparing the single injection and 
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continuous adductor blocks. The continuous group had a vascular injury at the time of 
catheter insertion and one catheter accidentally dislodged from its insertion site. 
Considering the similar outcome measures, extra time involved to place the catheter, 
catheter cost, as well as increased risk of complications in the continuous group, they 
recommended using a single-injection technique for adductor canal blockade 120. Some 
studies have yielded similar results to support these findings. Turner et al. 121 found that 
single-injection adductor canal blocks with multiple adjuvants (clonidine, 
dexamethasone and epinephrine) provided analgesia that was equivalent to a 
continuous adductor canal block up to 36 hours, though at 42 hours and beyond the 
continuous group was more effective 121. Lee et al. 122 performed a randomized non-
inferiority study comparing the single injection and continuous adductor canal block’s 
narcotic consumption at 12,24, and 48 hours post op, and failed to demonstrate that 
single-injection adductor blocks were inferior to continuous blocks for narcotic 
consumption at 12- and 24-hours post-op 122.  
Mudumbai et al. 119 sought to compare continuous adductor canal blocks with 
continuous femoral nerve blocks. The primary outcome was total ambulation distance 
achieved on post-op day 1 and 2. They set the minimal clinically important difference in 
ambulation distance at twice the distance in the adductor canal group compared to the 
femoral nerve block group. The study was sufficiently powered (power=0.8, a= 0.05, 
sample size=88) with 102 patients receiving a femoral nerve block and 66 receiving an 
adductor canal block.  Secondary measures included daily narcotic consumption, pain 
scores and length of stay in hospital. The results for the primary outcome showed that 
the adductor canal block group (37m, range 0–90m) had greater ambulation distance 
than the femoral group (6m, range 0–51m) on (p=0.001). These results carried forward 
to post-op day 2, with adductor canal blocks (60m, range 0-120) being superior to 
femoral blocks (21m, 0-78m) (p=0.003). These results were confirmed with the use an 
adjusted linear regression model. No differences in any other outcome measures were 
found. This study demonstrated the significant motor sparing benefits involved with 
adductor canal blocks over femoral nerve blocks 119.  
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In 2018, Leung et al. 123 conducted a randomized controlled trial comparing continuous 
adductor canal blocks with a control group. After exclusion and patient drop-outs, 70 
patients were included in the study, with 31 patients in the control and 39 patients in the 
continuous adductor canal group. They set their primary outcome as total opioid 
consumption in morphine equivalents. Secondary outcome measures were VAS pain 
scores measured as the area under the curve in the first 12- and 20-hours post-op, 
inpatient length of stay, knee range of motion, ambulation distance, and WOMAC 
scores. Blinding of the patients, as well as the outcome assessor was performed. The 
study was sufficiently powered, after setting a reduction of 20mg in opioid consumption 
to be clinically significant. The adductor canal block was performed under ultrasound 
guidance, with a bolus of 10ml of 0.25% bupivacaine into the adductor canal, followed 
by an 8ml/hr 0.125% bupivacaine infusion. The control group received a shame catheter 
through a simulated procedure, without perforation of the skin with a catheter to protect 
patients from unneeded harm. The study results revealed a significant increase in opioid 
consumption within the control group compared to the adductor canal block group at 20 
hours post-op (96.5 ± 47 mg vs. 73.9 ± 38 mg, 95% CI: −43.1 to −1.94 mg, p=0.03), but 
not at 12 hours (11.9 ± 14 mg vs. 12.5 ± 15 mg, 95% CI: −6.6–7.6 mg, p=0.89). No 
difference was found VAS pain scores between the two groups at 12 hours post-op 
(p=0.82) but were significantly improved at 20 hours post-op for the experimental group 
(adductor canal block) (p=0.04). No significant difference in length of stay was 
observed, and WOMAC scores at 6 weeks were present. With paired outcomes at 3- 
and 6-weeks post-op for range of motion, there was a significant improvement in range 
of motion compared to baseline range within the continuous adductor canal group 
(p=0.01). This study provided recent evidence for the efficacy of adductor canal blocks 
following total knee arthroplasty 123. 
Though the results with adductor canal blocks have been largely positive, there are still 
several factors that inhibit their wide-spread implementation. Nerve blocks are carried 
out prior to surgery and require resources such as regional block specialists, dedicated 
space, and ultrasound that add to the overall treatment cost. They also come with a 
host of risks, with procedure specific complications including neurovascular injury, 
dense motor blockade, and catheter site complications.  
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3.14 Continuous Wound Infusions:  
There has been a wide variety of techniques described for directly delivering 
anaesthetic to the knee joint including single-dose intraarticular injection, periarticular 
infiltration where multiple sites are systematically injected around the joint prior to 
wound closure, intraoperative placement of an Indwelling catheter with post-operative 
intermittent bolus or continuous infusion, or a combination of these methods 82,124. The 
use of indwelling catheters for wound infusion is similar to continuous perineural 
catheters in that the goal of treatment is to extend the duration of effective analgesia 81. 
Though there is concern in the surgical community though that indwelling catheters 
surrounding a prosthesis increases the risk of infection, studies that have explored the 
idea of continuous periarticular techniques have yielded variable results in terms of the 
risk of infection as well as its analgesic efficacy 81,106,110,125,126  
Ali et al. 110 conducted a randomized control trial comparing intraarticular catheters to 
single-injection periarticular infiltration in 200 patients undergoing total knee 
arthroplasty. In the experimental group (n=100), ropivacaine was infused intraarticularly, 
while saline was used in the control group (n=100). Intra-operatively, both groups 
received periarticular infiltration with 106mL of 2mg/ml ropivacaine, 30mg ketorolac and 
0.5mg epinephrine, and thus the comparison between a single injection and continuous 
method was made though this was not specifically stated. The continuous group’s 
infusion consisted of 7.5mg/ml ropivacaine set a t a rate of 2mL/hr, while the control 
received saline at the same rate. Their primary outcome measure was VAS score for 
pain, with secondary measures being complications, length of stay in hospital, opioid 
consumption, nausea and vomiting, range of movement and ability to straight leg raise. 
Continuous intraarticular infusion was found to only provide a statistically significant 
decrease in pain scores on post-op day one (12pm; p=0.02, 8pm p=0.03). None of the 
other time points on post-op day two or three were significant, and secondary outcomes 
were also insignificant. Infection was a clinically significant complication and occurred in 
13 patients in the study, 11 being in the experimental group (6 superficial, 5 deep 
infections) and 2 in the control (1 superficial, and 1 deep). All deep infections required 
surgery for their management (4 irrigation and debridement with polyethylene 
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exchange, two 2-stage revisions). Thus, continuous infusion did not extend the duration 
of analgesia as significantly as they had hypothesized and carried an increased risk of 
infection 110.   
Sun et al. 81 performed a meta-analysis of 10 clinical trials utilizing intra-articular infusion 
catheters versus placebo in 735 patients. Outcomes that were assessed were VAS 
scores a rest and activity at 24, 48, and 72 hours post-op, duration of surgery, length of 
stay in hospital, and complications. Their results revealed that continuous intra-articular 
infusion provided statistically significant decrease in VAS pain scores at 24 hours during 
rest (n=8 studies, p<0.01) and activity (n= 5 studies, p<0.01) and with activity at 48 
hours (n=5 studies, p<0.01). Continuous wound infusion was also associated with a 
significant decrease in nausea and vomiting (p=0.03). There were no differences in 
regard to pain at rest at 48 hours as well as during rest and activity at 72 hours between 
groups and length of stay was found not to be significantly different. What was 
significant between groups was the rate of infection, with the continuous infusion 
demonstrating an increased risk (RR 3.61; CI 95%, 1.18-8.5, p=0.02). Other 
complications such as DVT were not significantly different between groups. Sun et al. 
concluded that there was significant heterogeneity between studies due to the 
differences in study protocol and that there was a small number of trials (n=10) included 
with small sample sizes. Their results suggested that though continuous infusion 
provides prolonged analgesia at 24 hours with rest and mobilization and at 48 hours 
with mobilization, caution should be taken with its use until higher quality studies can 
definitively determine the risks such as infection 81.  
Randomized controlled trials directly comparing single-dose periarticular infiltration to 
continuous intraarticular are limited within the literature. Zhang et al. 125 randomized 96 
patients (80 completed the trial) to three different treatment groups, single-dose 
periarticular infiltration (n=27), continuous intra-articular infusion (n=27), and saline 
control group (n=26). The goal of the study was to provide evidence that continuous 
wound infusion would provide a longer duration of analgesia compared to a single-dose 
periarticular infiltration. The protocol called for periarticular infiltration of 150mL of 
2mg/mL ropivacaine, 30mg ketorolac and 0.5mg adrenaline in both the single and 
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continuous groups. Following surgery, the continuous group received a 4mL/hr infusion 
of 2mg/mL ropivacaine, and a 1.25mg/hr infusion of ketorolac for 48 hours. The primary 
outcome was VAS pain scores at 2, 4, 8, 12, 16, 20, 24, 30, 36, and 48 hours, with 
morphine consumption, functional recovery (maximum knee flexion at 7- and 90-days 
post-op), patient satisfaction and complications all serving as secondary outcomes. The 
analysis revealed that VAS scores were lower in the continuous infusion group 
compared to the single-dose infiltration group and were statistically significant at rest 
(p<0.05) from 8 to 48 hours post-op and during activity (p<0.05) from 16 to 48 hours 
post-op. Morphine consumption was significantly higher in the single-dose infiltration 
group (p<0.05). Maximum knee flexion at 7-and 90-days post-op was significantly 
increased in the continuous infusion group as well (p<0.05). The incidence of nausea 
and vomiting was higher in the saline control group compared to the peripheral block 
groups but was not statistically significant. Complications, infection, and satisfaction 
were not statistically significant between the single-injection and continuous groups. The 
results of this study indicated that, as hypothesized, continuous intraarticular infusion 
resulted in longer duration and superior analgesia over single- injection without a 
significant increase in complications 106.  
 
3.15 Summary:  
Pain following total knee arthroplasty is a complex issue. Patients have variable 
responses and anticipating their pain level can be challenging. Inadequate management 
of pain following surgery can lead to delays in mobilization, discharge, and an increased 
risk of complications such as deep vein thrombosis, pulmonary emboli, and pneumonia. 
Multi-modal analgesia utilizing oral medications and regional anaesthesia is an effective 
and safe method to manage patient’s pain following TKA, while reducing narcotic 
consumption and associated adverse effects 79. Regional nerve blocks provide a variety 
of benefits that include decreased opioid consumption, increased mobilization, 
increased patient satisfaction, and decreased post-operative complications by 
promoting ambulation 80. While single-injection techniques for these nerve blocks are 
effective, their duration of analgesia does not span the early phase post-operatively 
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when pain is at its worst 80,81. Continuous MSNB provides patients with effective 
analgesia over a longer duration compared to single-injection techniques and improved 
quadriceps function over femoral nerve blocks and epidural analgesia. This makes the 
use of continuous regional methods more appealing, but unfortunately, they are not a 
feasible option for all centers that perform total knee arthroplasty due to cost and 
resource constraints. Novel techniques for continuous regional anaesthesia need to be 
cost-effective, encourage narcotic stewardship, promote early ambulation to expedite 
discharge, and be void of complications such as increased infection, dense motor 
blockade, or high rate of failure. Periarticular infiltration and infusion may fulfill these 
criteria. Therefore, a randomized control trial comparing its efficacy to that of MSNB 
would add valuable information to the literature and perhaps a feasible option for 
surgeons who don’t have access to peripheral nerve blocks for their TKA patients.  
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Chapter 4  
4 Objectives 
The primary purpose of this randomized controlled trial is to assess whether 
periarticular infiltration and infusion has a comparable time-to-discharge to that of our 
previously investigated motor-sparing block technique in patients who have undergone 
primary total knee arthroplasty. Our secondary objectives are to compare the two 
groups analgesic quality through visual analogue scores, narcotic consumption and side 
effects, and physiotherapy progress including ability to perform and range of motion 
during assessments. We will investigate the rate of general and specific complications 
associated with each of the study arms. We also will be collecting patient reported and 
functional outcome scores using the Western Ontario McMaster Osteoarthritis Index 
and Knee Society Score. Patient satisfaction and quality of life will be measured using 
the Short Form 12 Survey.  
We hypothesize that there will be no difference in the time to discharge between our 
experimental group, periarticular infiltration and infusion, and our control, motor-sparing 
nerve block following primary total knee arthroplasty. We further hypothesize that 
periarticular infiltration and infusion will provide a comparable analgesic quality, 
physiotherapy progress, and narcotic consumption to that of motor-sparing nerve blocks 
while reducing procedure specific risks such as dense motor blockade. In doing this, we 
hope to provide evidence that supports the use of periarticular infusion so that resource 
constrained centers have a feasible anaesthetic option that is effective, promotes 




Chapter 5  
5 Materials and Methods 
5.1 Study Design:  
This regional anaesthesia study was conducted between September 2017 and June 
2018 (data collection ongoing) at London Health Sciences Centre (LHSC), University 
Hospital in London, Ontario. The study design was a non-blinded, randomized control 
trial with patients undergoing primary total knee arthroplasty. The study population was 
extracted from the practices of three staff arthroplasty surgeons following full-board 
ethical review and approval from the University of Western Ontario’s Human Subjects 
Research Ethics Board.  
 
5.2 Eligibility:  
Patients were identified through the internal appointment scheduling software (App Bar), 
having been scheduled for a unilateral, primary total arthroplasty procedure by one of 
the three participating study surgeons at LHSC, University Hospital. Our inclusion and 
exclusion criteria are listed in table 6. An initial screening for eligibility was conducted 
through the available clinical documents and information provided in our center’s 
electronic medical record. An inability to provide informed consent or perform study 
tasks due to psychiatric illness or cognitive impairment was set as an exclusion 
criterion. Patients with an allergy or intolerance to any of the pre-op, procedure related, 
or post-op medications were excluded. Patients who had a documented American 
Society of Anaesthesiologists (ASA) status of four from a previous surgical procedure, a 
history of chronic renal failure, had an absolute contraindication to regional and/or spinal 
anaesthesia, or were wheel-chair bound at the time of consultation were also excluded. 
A body mass index (BMI) of greater than 45 as well as long-term narcotic 
use/dependency or chronic pain (identified through the use of long-term use of potent 
analgesics) made patients ineligible for study inclusion. Potential participants who were 
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deemed appropriate for study involvement were approached in the preadmission clinic, 
where a secondary inclusion/exclusion screening took place.  
Table 6: Study Inclusion and Exclusion Criteria. 
Inclusion Criteria Exclusion Criteria 
1. Adult patients ASA physical status 1-3 
2. Ability to give informed consent 
3. No contraindications to regional techniques 
4. Ability to perform study related tests 
5. Scheduled for primary unilateral total knee 
arthroplasty 
 
1. Revision arthroplasty 
2. Allergy to local anesthetics and multimodal 
analgesic drugs 
3. Contraindications to spinal anaesthesia 
4. Inability to perform study related procedures 
5. Inability to give informed consent 
6. Wheel chair bound 
7. Pregnancy 
8. Chronic renal failure 
9. BMI >45 
10. Chronic pain managed with long-term opioid 
analgesia  
 
5.3 Subject Recruitment:  
Potential candidates who had received a consultation and booking for surgery by one of 
three participating arthroplasty surgeons were initially identified and pre-screened using 
our center’s electronic medical record. They were then formally approached for 
recruitment and screened for exclusion criteria in the surgical pre-admission clinic within 
three months of the time of surgery. Upon recruitment, several baseline patient 
characteristics were collected; Age, body mass index, date of surgery, side of surgery, 
previous surgery on operative knee, pre-operative diagnosis, and pre-operative 




5.4 Randomization:  
Randomization in this study was non-centralized and was performed using a random 
number generation method in Microsoft excel and sealed envelope allocation technique. 
Permuted block randomization into sets of 10 was utilized, with a one-to-one allocation 
ratio, to avoid having an unequal distribution of the two possible procedures throughout 
the trial (e.g. a span of 15 MSNB patients at the end of the trial). A third party not 
involved in the assessment of outcomes performed the random number generation in 
excel and group allocation was placed in a sealed envelope labelled with the 
corresponding study number. No stratification was performed.  
 
5.5 Blinding: 
There was no blinding in this randomized control trial for cost and logistical reasons. 
Performing two procedures, with one being a sham, would have been cost prohibitive 
for the trial due to the staff, and resources needed to perform both blocks. The logistics 
of implementing a sham block would have required independent anaesthesiologist 
involvement to avoid unblinding the care givers and the outcome assessors to mix the 




5.6.1 Motor-Sparing Nerve Block Control Group:  
This is a pre-operative regional anaesthetic technique that is conducted in the block 
room of our center’s PACU by a staff anaesthesiologist. For the purpose of having the 
ability to compare our results to part one of this two-part RCT, we utilized the same four 
injection site technique12. This block differs to a standard adductor canal block in that 
there are additional anaesthetic injections covering the posterior pericapsular area and 
lateral femoral cutaneous nerve to provide more widespread analgesia. Prior to initial 
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injection, midazolam intravenously was administered at the discretion of the 
anaesthesiologist to allow for patient sedation. Patient vitals were monitored using an 
electrocardiogram (ECG), pulse oximetry, and a non-invasive blood pressure monitor. 
With the patient supine, positioning the operative/procedure limb involved slight flexion 
of knee, with external rotation at the hip and was followed by an initial pre-procedural 
scan assessing the four injection areas of interest. Sterile preparation of the leg was 
done with the use of dyed chlorohexidine and sterile draping to reduce the risk of site 
infection.  
The initial bolus injection cocktail was prepared in the block room at the time of the 
procedure. With the use of a 60 mL sterile syringe, a solution containing 0.5% 
ropivacaine, 2.5 ug/ml of epinephrine, 10 mg of morphine, and 30 mg of ketorolac for a 
total volume of 60mL. The solution was injected at the four following sites, intermediate 
cutaneous nerve of the thigh, adductor canal (where the continuous catheter is placed), 
posterior pericapsular injection, and lateral femoral cutaneous nerve to provide a 
thorough regional block. 
5.6.1.1 Intermediate Cutaneous Nerve of the Thigh (5mL bolus):    
The first step of the procedure was the identification of neurovascular structures 
in the lower limb with the use of ultrasound guidance. The femoral artery was identified 
proximally at the groin and is traced along its path deep to the sartorius muscle. Once 
the superior geniculate artery branch is located, the probe is turned 90 degrees and 
moved superiorly again 8 to 10cm proximally and is marked as the site for injection. 
What is looked for on ultrasound is the presence of a peripheral nerve laying in the 
intermuscular plane between the rectus femoris and Sartorius muscles superficial to the 
fascia lata. Following local skin anaesthesia with 1% lidocaine injection, an eight- 
centimeter Tuohy block needle is inserted at the pre-marked site, avoiding the major 
neurovascular structures with the safe guidance of ultrasound. Once the needle is 
superficial to the facia lata, the tip is redirected within the fascia of sartorius and 5mL of 
the injection solution is delivered in the perineural area of the intermediate cutaneous 




Figure 7: Ultrasound Image of the intermediate cutaneous nerve of the thigh 
injection 
5.6.1.2 Adductor Canal (25mL bolus): 
Following the intermediate cutaneous nerve of the thigh injection, the needle is 
simply redirected and advanced through the facia lata until the tip lies adjacent to the 
femoral artery, deep to sartorius. A further local anaesthetic bolus of 20ml is delivered 
within the adductor canal while being monitored on ultrasound using a colour doppler to 
ensure proper needle tip placement and study drug administration around the femoral 
artery and saphenous nerve. Prior to removal of the Tuohy needle, a flexible regional 
catheter is placed using the seldinger technique, with the tip extending 3cm past the tip 
of the needle. A further 5mL of study drug are delivered through the catheter for a total 
of 25mL of study solution being injected into the adductor canal (figure 8). The catheter 
insertion site is covered by a sterile tegaderm dressing and the free end of the catheter 
is attached to an adaptor that allows for the CADD infusion line to be connected, 





Figure 8: Ultrasound image of the adductor canal injection 
 





5.6.1.3 Posterior Pericapsular injection (25mL bolus)  
Following the previously described steps, a pre-injection scan is utilized to mark 
the site of injection and anaesthetized using lidocaine. Under ultrasound guidance, the 
Tuohy needle is inserted within close proximity of the medial femoral epicondyle, and 10 
cm from the knee joint line. Once confirmation of needle tip placement using colour 
doppler, a bolus injection of 25mL of study drug is administered to the area between the 
posterior aspect of the femur and the popliteal artery (figure 10).  
 
 
Figure 10: Ultrasound Image of the posterior pericapsular injection 
5.6.1.4 Lateral Femoral Cutaneous Nerve (5mL bolus)   
The final injection in our study control regional block is the lateral femoral 
cutaneous nerve (LFCN). It’s identified by using the ultrasound to trace sartorius back to 
its origin at the anterior superior iliac spine. This is where the lacuna musculorum is 
located between the origin of sartorius and tensor fascia lata and is where the LFCN 
resides, and the injection site is marked and anaesthetized. The remaining 5mL of study 
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solution are injected within this area following needle tip position confirmation on 
ultrasound and concludes the motor sparing nerve block procedure (figure 11).  
 
Figure 11: Ultrasound Image of the intermediate cutaneous nerve of the thigh 
injection 
5.6.2 Periarticular Infiltration and Infusion Experimental Group:  
Periarticular Infiltration and infusion (experimental group) is a regional 
anaesthetic method that is conducted intraoperatively by the surgical team. The local 
infiltration injection comes in a pre-made sterile solution provided by our center’s 
operating room Pyxis. The solution is provided in a standard 110ml volume of 0.5% 
ropivacaine, 10mg of morphine, and 30mg of ketorolac. Toward the end of the case, 
following completion of the index procedure and preparation for surgical site closure, the 
surgeon injected variable volumes of infiltration anaesthetic throughout the knee joint 
within the exposed soft tissues.  
Following infiltration of the knee, the next step was placement of the continuous 
infusion catheters, part of the periarticular infusion kit produced by Pajunk. These three, 
small gauge infusion catheters are uniquely constructed being 900mm in length total, 
with the most distal 75mm having 30 micro perforations 360-degrees around the 
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circumference to allow equal fluid distribution to the area. The rest of the kit includes 
three clamping adaptors to attach the catheters to the three-way splitter, as well as a 




Catheter placement is performed with the use of the seldinger technique, using the 
Tuohy needle to guide the flexible infusion catheters to their desired position. Prior to 
Tuohy needle insertion the placement is finalized by marking three points superiorly, 
from anterior to posterior (figure 13).  
Pajunk Periarticular Catheter Kit  
Contents: 
1. Catheter Sheath x 3  
2. Three-way Connector x 1  
3. Clamping adaptors x 3 
4. Tuohy Needle x 1 
5. Tuohy Needle Stylus x 1   
6. Infiltralong Catheter x 3  
              -19Gx 900mm 
                           -30 holes/75mm 
 




Figure 13: Catheter placement from anterior and lateral views 
5.6.2.1 Subcutaneous Catheter:  
Insertion site one is positioned approximately two inches superior and two inches lateral 
to the superior pole of the patella and is for placement of the subcutaneous catheter. 
The Tuohy needle is inserted, and the needle tip is identified under direct visualization 
within the subcutaneous space. A catheter, within its protective sheath, is fed through 
and pulled to the desired length internally, leaving four black markings visible externally 





Figure 14: Infiltralong catheter markings and perforated section 
5.6.2.2 Intraarticular Catheter:  
Using the same direct visualization technique utilized for the subcutaneous catheter, the 
intraarticular catheter is placed at the second marked position, slightly more posterior to 
the subcutaneous insertion site prior to surgical closure of the arthrotomy. The catheter 
is then placed in the lateral gutter intraarticularly to allow unrestricted range of 
movement and reduce the rick of the catheter becoming lodged in between the 
articulating components.  
5.6.2.3 Posterior Catheter Placement:  
The posterior catheter uses a different method of placement, as it cannot be visualized 
directly once in situ. The catheter insertion sight is dictated by firstly palpating the lateral 
epicondyle of the distal femur, moving proximally past the metaphysis to the most distal 
portion of the diaphysis, approximately 3 to 5cm from the epicondyle. The Tuohy needle 
is inserted from lateral to medial directly perpendicular to the femoral shaft and once the 
needle comes into contact with the lateral cortex, is gently redirected posterior along the 
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surface of the cortex a further 2cm. Once the needle is in position, the stylus is removed 
and a 10ml syringe containing sterile saline is used to initially aspirate to ensure the 
needle tip is not intravascular. Once deemed safe, the saline bolus is delivered to create 
space for the final catheter and the syringe is removed to allow delivery of the catheter.  
Once all three catheters are in position, their exposed ends were attached to the 
clamping adaptors and connected to the three-way splitter where the whole system is 
primed with sterile saline. Finally, the entry sites were sealed with dermabond and 
covered with a tegaderm dressing to reduce the risk of infection as well as protect the 
catheters from mistakenly being dislodged from their site.  
 
5.7 Standardization of Study Groups:  
Wanting to keep the two study populations as similar as possible, a number of 
standardized pre and post-surgical protocols were set. Beginning just after the time of 
admission on the day of surgery, patients, with a permitting medical status, received a 
pre-operative multimodal analgesic regimen consisting of 975mg Acetaminophen, 
300mg Gabapentin, and 500mg Naproxen orally in the block room. The use of pre-
operative non-steroidal anti-inflammatories as well as neuropathic analgesics has been 
shown to decrease post-operative pain and opioid consumption 69. Prior to being 
transferred to the operating room for their procedure, a spinal anaesthetic was 
performed by and anesthetist under titrated sedation containing 15mg of hyperbaric 
bupivacaine with no intrathecal opioids. The initial bolus in both groups were also 
standardized containing 0.5% ropivacaine, 30mg Ketorolac, and 10mg of morphine, 
being delivered through either ultrasound guided injections pre-operatively in the MSNB 
group or through periarticular infiltration in the experimental group intraoperatively. 
150mcg of Epinephrine were also added to the MSNB injection as per protocol in our 
previous study, where it was not included in the knee infiltration cocktail due to the risk 
of contamination of the previously described standard infiltration solution that is readily 




In terms of intra-operative surgical standardization, all patients underwent a primary 
total knee arthroplasty using one of two implant options; Depuy Attune or Stryker 
Triathlon. Cases were performed with the use of a tourniquet for a bloodless technique 
and the addition of patellar resurfacing during the procedure was left to the surgeon’s 
judgement. 
Post-operatively, the basal infusion in either group was commenced in the post-
operative care unit with the use of a continuous ambulatory delivery device (CADD 
pump). The infusion drug administered was 0.2% ropivacaine, set at a basal rate of 8 
milliliters per hour (lock-out of 8.1 milliliters), with the option of a patient-controlled bolus 
being removed. For breakthrough or uncontrolled post-operative pain, a standardized 
multimodal analgesic order-set consisting of 650mg Acetaminophen Q6h, Naproxen 
500mg Q12h, Tramadol 50mg Q4h PRN, Hydromorphone Tablets 2-4mg Q3h PRN, 
and Hydromorphone Subcutaneous Injection 1mg Q3h PRN. Catheter removal was 
contingent on the patient meeting criteria for discharge, with readiness for discharge 
being dictated by our center’s standard protocol. 
A communication order made in the study’s EMR order-set stated the Hold 
catheter or MSNB infusion at 6am post-operative day 2 or day of discharge, whichever 
comes sooner.” This allowed for a more accurate assessment of pain prior to regional 
block removal and for possible post-operative day one discharge in patients who 
progressed through the post-op milestones more rapidly. Upon meeting criteria for 







5.8 Outcome Measures:  
The following outcomes were measured at various time-points depending on the type of 
data collected. Figure 15 is a time-line displaying the outcomes collected at various 
time-points.  
 
Figure 15: Timeline of outcome data collection 
5.8.1 Primary Outcome Measure: 
The primary outcome measure was set as time-to-discharge in this study. This was 
defined as the time at admission to the time of discharge. There are a variety of factors 
that can delay patient’s early discharge following a total knee replacement. Poor pain 
control is a common cause to delay discharge but can also be a major component in 
other post-operative issues. Inadequate analgesia can lead to an increase in opioid 
related complications (Ileus/constipation, nausea/vomiting, delirium, sedation, 
respiratory depression), inability to perform physiotherapy exercises and milestones 
required for discharge, and cause patient to be unwilling to go home. All known 
complications suffered by inpatients were recorded to both ensure there weren’t any 
major adverse events associated with one of the groups, and to be taken into 




Readiness for discharge is dictated by our center’s discharge protocol found below. The 
care team, specifically the attending surgeon/team resident and physiotherapist, assess 
and determine if patients have satisfactorily met these criteria. 
Discharge Criteria:  
1. Patient able to complete daily tasks such as get in and out of a chair or bed, get 
off and on the toilet, walk a suitable distance (30m) with proper walking aids 
without a time limit, and navigate an acceptable number of stairs.  
2. Have no medical or surgical complications including urinary catheterization or 
need for blood transfusion 
3. Acceptable pain relief (NRS = 5/10) without any need for intravenous analgesics. 
4. No nausea/ vomiting; generalized weakness or dizziness. 
5. Knee flexion of 900 is optional but preferred. 
With these criteria, an effective regional anaesthetic technique must work to expedite 
the post-operative process by treating patient’s pain, while reducing the risk of 
potentially discharge delaying complications and be cost-effective. With the ever-
increasing cost of healthcare, exploring possible care options that reduce the inpatient 
stay of patients is important to the future of patient management following total knee 
arthroplasty.  
5.8.2 Secondary Outcome Measures:  
Numerous secondary outcomes were measured throughout the study period. This 
allowed for collection of possible confounders that could affect a patient’s time to 
discharge, as well as ensure no significant functional differences occurred between the 
two groups.  
5.8.2.1 Numeric Pain Rating Scale (NPRS):  
A numeric pain scale was utilized in the study to assess patient’s subjective pain levels 
both at rest and during activity. Activity was described as any major movement of or 
weightbearing on operative leg. The 11-point scale, measuring 0-10 (10 being the worst 
pain ever experienced) was assessed using a visual analogue scale (VAS). This model 
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has been verified by Williamson et al.127 and was found to be highly sensitive, reliable, 
and easy to obtain. Pre-operative baseline scores were collected on the day of surgery 
before commencement of the spinal anaesthetic. VAS scores were collected post-
operatively at six hours, and then again at 9am and 2pm during each inpatient post-
operative day by a study assessor. Upon discharge, patients were instructed on the use 
of a pain dairy to chronical their own scores for four more post-discharge days.  
5.8.2.2 Narcotic Consumption:  
Narcotic consumption post-operatively was collected at six hours, 9 am and 2pm of 
each inpatient post-operative day, and during the four days post-discharge by patients 
through the pain dairy. The time, dose and frequency were recorded from the 
medication administration record available in the our EMR, as well as from the patient’s 
pain diary. All narcotic medications were converted to morphine equivalence for 
comparison between the two groups.  
5.8.2.3 Physiotherapy status:  
Physiotherapy progress was recorded at the time of each assessment during the 
patient’s inpatient stay. Patient’s ability to perform physiotherapy and complications that 
inhibited their ability were documented. Progress was measured through range of 
movement by the staff physiotherapists. These measurements are involved in the 
criteria for discharge and can be affected by the efficacy of a patient’s analgesic 
modality.  
5.8.2.4 Complications/Adverse Events:  
All complications, regardless of being directly, indirectly or not contributable to the 
surgical procedure were recorded. Information documented regarding the complication 
included the diagnosis, date, treatment administered, whether a delay in discharge 
occurred because of it, and the discharge day following successful management. 
Complications being monitored include the rates of myocardial infarction, deep venous 
thrombosis, pulmonary emboli, paralytic ileus, gastrointestinal bleed, new onset renal 
dysfunction, wound infection, as well as procedure specific complications such as dense 
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motor block in the MSNB group. This will allow us to control for a possible confounder in 
the final analysis.  
5.8.2.5 Side Effects:  
At the time of each inpatient visit as well as during assessment time points in the pain 
diary, side effects that were collected included the presence of nausea or vomiting as 
well as sedation. Patients used a five-point evaluation scale for nausea with none, mild, 
moderate, severe, extreme as options. For sedation, a 5-point scale of 0-5 was utilized, 
with 0 being not sedated, to 5 being nearly unable to stay awake. 
5.8.2.6 Vital Sign Data:  
During in-patient data collection visits, research staff collected data pertaining to the 
most recent vital signs recorded by the nursing staff, specifically looking at respiratory 
rate, pulse oximetry as well as whether the patient was breathing on supplementary 
oxygen or room air. This was to assess for the presence of respiratory depression 
associated with narcotic medications being used for breakthrough pain in the post-
operative multimodal analgesic order set.  
5.8.3 Functional outcomes:  
Functional outcomes following total joint arthroplasty are an important and expected 
measurement in trials. A procedure that causes a significant deviation in the expected 
functional outcomes of patients should not be considered for implementation into 
practice. 
5.8.3.1 WOMAC:  
The Western and McMaster Universities Osteoarthritis Index is a patient reported 
outcome measure that assesses symptoms and physical disability caused by 
osteoarthritis of the hip or knee. There are a number of tailored questions that are 
designed to evaluate three specific categories including pain (five questions, score 0-
20), stiffness (two questions, score 0-8), and subjective physical function (17 questions, 
score 0-68). The three scores create individual numeric values for each of the three 
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dimensions as well as a total score that correlates with the severity of the patient’s 
symptoms. The version used in our study is called Likert version, which uses a scale of 
none (0), mild (1), moderate (2), severe (3), and extreme (4), with a higher score 
indicating a worse symptom/functional state. The WOMAC also allows healthcare 
providers a means of evaluating clinically important changes in health status over time 
following administration of an intervention128.  
The WOMAC is a validated tool that when applied to total knee replacement trials, can 
provide reliable and sensitive outcome data. A literature review of 43 articles conducted 
by McConnell et al.129 found that the internal consistency for pain, stiffness, and 
physical function measured 0.86, 0.90, and 0.95 respectively.  
In our study, it was decided a baseline WOMAC score would be collected at the pre-
admission appointment, with post-operative reassessments occurring at the 6-week and 
3-month follow-up visits.  
5.8.3.2 The New Knee Society Score:  
The new Knee Society Score (KSS) is a combined subjective (patient) and objective 
(clinician) outcome measurement tool. The original Knee Society Clinical Rating Tool, 
developed in 1989, allowed for the objective measurement by healthcare providers of a 
patient’s functional abilities both pre and post-operatively following TKA. The validity of 
the original tool diminished over time with the greater importance of patient’s 
expectations, demands, and functional requirements being realized130.   
The new Knee Society Scoring system was developed and validated in 2011 to take 
these considerations and incorporate them into a more contemporary model and 
includes both a pre-operative and post-operative version. A combination of patient 
reported outcomes as well as a physical and radiographic assessment carried out by 
the clinician. For the functional component of the survey scores are created in four 




The objective score and purely clinician assessed component includes physical 
examination findings, and radiographic components. These questions include a VAS 
pain score, range of movement, presence of flexion contracture (points deducted 
depending on degree), presence of extension lag (points deducted depending on 
degree), ligamentous stability, and radiographic alignment.  
5.8.3.3 SF-12 Health Survey:  
The Short Form Survey 12, or SF-12, is a condensed version of SF-36 health survey 
that aims to evaluate a patient’s personal view on the status of their over-all health, both 
mental and physical. The SF-12 is a validated, reliable and responsive patient reported 
outcome measure131. The content of the questions covers physical function (two 
questions), bodily pain (one question), general health perceptions (one question), vitality 
(one question), social functioning (one question), emotional problems interfering with 
social activities (two questions), and finally, general mental health (two questions)131. 
The scores from these questions are then applied to an overall SF-12 physical and SF-
12 mental health scores, with a range of zero (worst possible health state) to 100 (best 
possible health state).  
Again, a baseline score was taken at the pre-admission appointment, with post-
operative values coming from the 6-week and 3-month follow-up visits.  
 
5.9 Sample Size:  
In a case study conducted by Kerr and Kohan et al.101 involving 325 patients, it was 
found that the overnight discharge rate with local wound infiltration was 71%. We expect 
a 30% improvement in the overnight discharge rates for patients who receive a motor 
sparing nerve block.  
A formal equality sample size calculation was performed with a two- sided alpha error 




5.10 Data Analysis: 
We analyzed all data from patients with an intention to treat analysis using SPSS 
Version.24 (IBM Corp, Armonk, NY). For patient demographic characteristics, we 
employed the use of descriptive statistics, comparing the means and reporting the 
standard deviations for continuous variables (age, height, weight, BMI), and proportions 
for nominal variables132. 
For the analysis of our primary outcome, time to discharge, we used a Mann-Whitney U 
Analysis with Bonferroni correction due to the inherent lack of data normality. The 
dependent variable was time to discharge and the group allocation (MSNB or LIA and 
infusion) was the independent variable. For secondary outcomes, we utilized a 
multivariate analysis of covariance (MANCOVA) to compare VAS pain scores at rest 
and activity at the various data collection time points. The dependent variable was VAS 
score, the group allocation (MSNB or LIA and infusion) the independent variable, with 
baseline VAS scores (rest and activity) served as covariates132,133.  
 Multivariate analysis of variance (MANOVA) was performed for narcotic consumption 
(in morphine equivalence), respiratory rate and oxygen saturation to compare the 
groups at each inpatient time point.  An analysis of covariance (ANCOVA) was 
performed for patient reported outcome measures (SF-12, WOMAC, KSS), as well as 
physiotherapy range of movement. Baseline WOMAC, SF-12, KSS scores, and 
preoperative range of movement were used as covariates respectively. If data was 
found to be not normally distributed, we used a Mann-Whitney U statistical test to 
compare the two groups, and a Bonferroni correction was utilized to correct for multiple 
comparisons132. 
We set significance at p<0.05 and reported the unadjusted mean with 95% confidence 
intervals (CI) in figures. In the tables and text, the adjusted mean (means adjusted to 
the presence of the covariate) with standard error (SE) was stated as well as the 
adjusted mean difference with 95% CI. For missing data points, the last outcome carried 









6 Results   
6.1 Participant Flow  
Following pre-screening using our hospital’s electronic medical record, patients were 
approached through the preadmission clinic prior to surgery to be assessed for study 
eligibility. Participant flow through the study is demonstrated in Figure 16. From October 
2017 to May 2018, a total of 422 patients were screened for the study. Of this group, 72 
patients were randomized, with 75% (n=54) successfully enrolled in the trial. In the 
motor sparing nerve block group (MSNB), there were 29 patients and in periarticular 
Infiltration and infusion group (LIA and infusion) there were 25. Demographic data is 
provided in Table 7. All 54 patients had inpatient VAS, physiotherapy, and narcotic 
consumption data, with 42 patients reaching the end of the trial (3-months) at the time of 
analysis. Study power was not achieved, and the following results are from an interim 
analysis.   
Patient ineligibility was determined utilizing previous medical documentation or during 
the preadmission interview. The most common reasons for exclusion were chronic pain 
and pre-operative narcotic use (n=78), enrollment in another study (n=65), declining to 
participate (n=45) and BMI >45 (n=36).  
Twenty-five percent (n=18) of the enrolled patients were excluded following 
randomization. Reasons included violation of study protocol (n=1), undisclosed allergy 
to a study drug (n=1), non-disclosure of pre-operative narcotic abuse (n=1) and 
contraindicated to MSNB due to recent anticoagulation (n=1). Other reasons were 
changed date of surgery (n=1), failure of block catheter placement (n=2), two patients 
dropped out of the study prior to surgery, and unknown chronic renal impairment (n=2). 
Seven patients were unable to participate in the study due to an unforeseen nationwide 
supply shortage of ropivacaine, resulting in a study hiatus. No study participants 





Figure 16: Participant flow through the study 
Table 7: Patient Demographics 
Characteristic Motor Sparing Knee Block 
(n=29) 
Periarticular Infiltration and 
Infusion (n=25) 
Male, n (%) n= 14 (48%) n= 13 (52%) 
Mean Age ± SD, y 68 ± 8.37 65 ± 9.56 
Mean Height ±SD, cm 169 ± 10.07 169 ± 10.66 
Mean Weight ± SD, kg 90 ± 18.06 91 ± 18.55 
Mean BMI ± SD, kg/m2 31.85 ± 5.42 31.96 ± 6.02 





















n= 1 (3%) 
 
n=24 (96%) 
n= 1 (4%) 
















SD = standard deviation, BMI = body mass index, ASA = American Society of 
Anaesthesiologists physical status classification system 
 
6.2 Primary Outcome Measure:  
6.2.1 Time to Discharge from Hospital:  
There were no statistically significant differences in the times to discharge between the 
motor sparing nerve block and the periarticular infiltration and infusion groups (p= 0.47). 
The mean time to discharge for the MSNB group was 2.57 days (SD ± 1.0), while the 
LIA and infusion group was 2.5 days (SD ± 1.25). Both groups had similar mean time to 
discharge and are both skewed towards a short duration in hospital as demonstrated in 





Figure 17: Distribution of time to discharge from hospital for MSNB and 
periarticular infiltration and infusion 
75 
 
6.3 Secondary Outcome Measures:  
6.3.1 Visual Analogue Scale Pain Scores  
Visual analogue scale (VAS) pain scores were collected for both groups at each 
inpatient time point as well as following discharge through the pain diaries. VAS scores 
at rest as well as with activity were documented individually. Data was collected at six 
hours post-op and for six post-operative days, twice daily, for a total of 13 collection 
points.  
 
6.3.2 Visual Analogue Scale at Rest:  
Using the pillai’s trace test with MANCOVA analysis, there was not a significant 
difference for VAS scores at rest between the two groups, MSNB and LIA, when 
controlling for pre-operative VAS rest scores (V=0.3, F (13,39) = 1.28, p=.266). Table 8 
displays the adjusted means for both groups at each time point. Separate univariate 
ANCOVAs did show a significant difference in VAS rest pain scores between the 
adjusted means at 6 hours post-op (F (2, 51) = 4.46, p= 0.016) with the MSNB group 
having superior analgesia less.  No other time points were statistically significant. The 
covariate for pre-op VAS score at rest did not have a significant effect on the outcome 
(post-op pain at rest) V=0.27, F (13, 39) = 10.9, p=0.39. Figure 18 graphically displays 













MSNB mean ± 
SE 




6 hours 2.09 ± 0.45 3.97 ± 0.48 -1.88 (-3.21 to -
.551 
p=0.007 
POD1   9am 3.30 ± 0.42 4.09 ± 0.45 -0.78 (-2.03 to 
0.47) 
p=0.21 
POD1   2pm 3.02 ± 0.39 3.66 ± 0.41 -0.65 (-1.80 to 
0.51) 
p=0.26 
POD2   9am 2.71 ± 0.33 1.99 ± 0.36 0.79 (-0.19 to 
1.78) 
p=0.11 
POD2   2pm 2.81 ± 0.35 2.14 ± 0.38 0.67 (-0.37 to 
1.72) 
p=0.20 
POD3   9am 2.79 ± 0.36 2.64 ± 0.39 0.15 (-0.84 to 
1.15) 
p=0.75 
POD3   2pm 2.76 ± 0.36 2.61 ± 0.39 0.15 (-0.912 to 
1.21) 
p=0.77 
POD4   9am 2.67 ± 0.41 2.67 ± 0.44 0.00 (-0.1.6 to 
1.07) 
p=0.99 
POD4   2pm 2.83 ± 0.38 2.76 ± 0.41 0.06 (-0.15 to 
1.28) 
p=0.91 
POD5   9am 2.81 ± 0.37 2.46 ± 0.40 0.36 (-0.78 to 
1.48) 
p=0.52 
POD5   2pm 3.05 ± 0.37 2.47 ± 0.40 0.62 (-0.89 to 
1.1) 
p=0.26 
POD6   9am 2.75 ± 0.34 2.85 ± 0.36 -0.11 (-1.1 to 
0.88) 
p=0.83 






Figure 18: VAS scores at rest between MSNB and LIA and infusion groups 
(unadjusted means) 
 
6.3.3 Visual Analogue Scale with Activity:  
Following MANCOVA analysis and pillai’s trace test, there was not an overall significant 
treatment effect between MSNB and periarticular infiltration, when controlling for pre-
operative activity VAS pain scores on the reported VAS for pain during activity (V= 0.37, 
F (13,39) = 1.76, p=0.086). Table 9 displays the adjusted means for both groups at 
each time point. Separate univariate ANCOVAs did show a significant difference in VAS 
activity scores between the adjusted means at three time points; 6 hours post-op (F (2, 
51) = 9.03, p< 0.001); 2pm Post-op day (POD) 1 (F (2, 51) = 8.59, p= 0.001); 9am POD 
2 (F (2,51) = 4.24, p= 0.02). MSNB had superior analgesia at 6 hours post-op and 2pm 
POD 1, but LIA and infusion was superior at 9am POD 2. No other time points were 
statistically significant. The covariate for pre-op VAS score during activity did have a 
significant effect on the post-op VAS scores (V=0.40, F (13, 39) = 2.05, p=0.04). Figure 
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MSNB mean ± SE LIA and Infusion 





6 hours 3.34 ± 0.46 5.87 ± 0.49 -2.48 (-3.84 to -
1.126) 
p=0.001 
POD1   9am 6.29 ± 0.41 7.03 ± 0.44 -0.74 (-0.48 to 
1.95) 
p=0.22 
POD1   2pm 5.97 ± 0.37 7.23 ± 0.40 -1.27 (-2.35 to -
0.85) 
p=0.02 
POD2   9am 5.84 ± 0.35 5.35 ± 0.38 0.49 (-0.55 to 
1.53) 
p=0.34 
POD2   2pm 5.29 ± 0.43 5.27 ± 0.46 0.02 (-1.24 to 
1.27) 
p=0.9 
POD3   9am 5.34 ± 0.44 5.66 ± 0.48 0.08 (-1.23 to 
1.38) 
p=0.90 
POD3   2pm 5.36 ± 4.49 5.74 ± 0.47 -0.39 (-1.68 to 
0.92) 
p=0.56 
POD4   9am 5.02 ± 0.47 5.34 ± 0.50 -0.31 (-1.70 to 
1.08) 
p=0.65 
POD4   2pm 5.17 ± 0.49 5.13 ± 0.53 0.04 (-1.38 to 
1.49) 
p=0.95 
POD5   9am 5.46 ± 0.48 5.12 ± 0.51 0.32 (-1.08 to 
1.72) 
p=0.64 





POD6   9am 5.24 ± 0.49 5.20 ± 0.52 0.04 (-1.37 to 
1.45) 
p=0.95 





Figure 19: VAS scores during activity between MSNB and LIA and infusion 
groups (unadjusted means) 
Below, Figures 20 and 21 combine the rest and activity VAS unadjusted means 
for each group to graphically display the magnitude of difference between the two 
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Figure 20: MSNB VAS scores at rest and during activity (unadjusted means) 
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6.3.4 Narcotic Consumption:  
Inpatient narcotic consumption between time points was converted to morphine 
equivalence and the groups were compared (figure 22). There was no overall 
statistically significant difference in narcotic consumption between the two groups 
(pillai’s trace V=0.073, F (5, 48) = 0.76, p= 0.59). There were also no significant 
differences at any of the time points between group unadjusted means (Table 10).   
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Table 10: Narcotic consumption in morphine equivalents (unadjusted means) 
Time Point Post-
op 
MSNB mean ± SE LIA and Infusion mean ± SE 
6 hours 
2.66 ± 1.17 
4.64 ± 1.26 
POD1   9am 23.66 ± 4.50 32.72 ± 4.85 
POD1   2pm 12.00 ± 1.98 15.84 ± 2.13 
POD2   9am 34.621 ± 5.14 45.440 ± 5.54 
POD2   2pm 20.310 ± 4.35 25.200 ± 4.69 
 
6.3.5 Side Effects:  
6.3.5.1 Nausea:  
Nausea is a common side effect as a result of narcotic use and was quantitatively 
assessed using a 0-4 numeric scale (0=none, 1=mild, 2=moderate, 3=severe, 4= 
extreme). There was no significant overall difference in nausea scores between 





Figure 23: Nausea scores (unadjusted means) 
6.3.6 Inpatient Respiratory Rate and Oxygen Saturation: 
Patient vitals were collected at each post-operative timepoint to ensure there were no 
significant respiratory side effects because of large quantities of narcotic medications.   
There were no statistically significant differences in respiratory rate (p=0.54) and oxygen 
saturation (p=0.67) between groups during the in-patient stay.  
 
6.3.7 Physiotherapy:  
While patients were in hospital, the ability to perform physiotherapy was noted by 
documenting the time point they had successfully performed physiotherapy by. There 
was no statistically significant difference (p=0.49) between groups in their ability to 
begin physiotherapy (means ± SD, time point; MSNB 2.07 ± 1.13, LIA and infusion 1.96 
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Range of movement (ROM) post-op was analyzed using two different outcomes, one 
being first ROM measured during physiotherapy and the other best achieved ROM 
while in hospital. Pre-operative ROM served as the covariate to control for baseline 
differences. There was no statistically significant difference in first measured ROM 
between groups post-operatively (F (2,51) = 1.51, p= 0.23). There also was no 
significant difference between groups comparing best achieved ROM while in hospital 
(F (2, 51) = 1.98, p= 0.15).  
 
6.3.8 Two-week Follow-up Data:  
6.3.8.1 Vas Pain Scores:  
VAS rest and activity scores were collected at the 2-week post-operative visit. The pre-
operative VAS scores were used as a covariate during analysis. There were no 
statistically significant differences in VAS scores at two weeks post-op during rest (F (2, 
51) = 0.535, p= 0.59) or activity (F (2, 51) = 1.51, p= 0.23). Table 4 displays adjusted 
means to the covariate for each group.   
Table 11: VAS score adjusted means at two weeks 
VAS Score MSNB mean ± SE LIA and Infusion mean ± SE 
Rest 2.39 ± 0.36 2.15 ± 0.39 
Activity 4.12 ± 0.40 4.1 ± 0.44 
 
6.3.8.2 Range of Movement:  
There was no statistically significant difference in range of movement between groups 




6.3.9 Patient Reported Outcome Measures:  
Patient reported outcome measures including 12-item short-form survey (SF-12), 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Knee 
Society Score (KSS) were collected pre-op and again at 6-weeks and 3-months post-
op. Data that was found to be not normally distributed prior to analysis included pre-op 
SF-12, Objective Knee Indicators, 6-week KSS symptoms, and 3-month KSS 
symptoms, and Objective Knee Indicators. Only one data point was found to be 
statistically significant. The KSS Expectations subsection was statistically significant 
between groups at the 6-week post-operative assessment (F (2, 51)= 4.78, p = 0.012). 
All other outcome measures at both the 6-week and 3-month post-operative timepoints 
were not significant. The adjusted means are reported below for SF-12 (table 12), 
WOMAC (table 13), and KSS (table 14).  
Table 12: SF-12 patient reported outcome data 
Time Point SF-12 
Component 
MSNB mean ± 
SE 
LIA and Infusion 
mean ± SE 
Sig. 
Pre-op SF-12 Mental 55.60 ± 1.50 52.79 ± 1.88 p= 0.07  
SF-12 
Physical 
33.73 ± 1.91 36.91 ± 1.80 p= 0.20 
6-week SF-12 Mental 53.49 ± 1.6 53.90 ± 1.72 p=0.86 
SF-12 
Physical 
33.80 ± 1.51 35.44 ± 1.5 p=0.43 
3-month SF-12 Mental 56.19 ± 1.34 54.79 ± 1.44 p=0.48 
SF-12 
Physical 





Table 13: WOMAC Total patient reported outcome data 
Time Point MSNB mean ± 
SE 
LIA and Infusion 
mean ± SE 
Sig. 
Pre-op 51.42 ± 3.64 56.63 ± 3.69 p=0.277 
6-week 67.23 ± 2.20 65.01 ± 2.37 p=0.499 
3-month 73.23 ± 2.65 71.40 ± 2.85 p= 0.64 
 
Table 14:KSS patient reported outcome data (bold indicates significant time 
point) 
Time Point KSS 
Component 
MSNB mean ± 
SE 
LIA and Infusion 
mean ± SE 
Sig. 
Pre-op Symptoms 15.52 ± 0.80 18.04 ± 1.07 p= 0.13 
Expectations 13.89 ± 0.26 12.56 ± 0.61 p= 0.06 
Satisfaction 15.45 ± 1.56 19.48 ± 1.79 p=0.07 
Functional 
Activity 




35.89 ± 3.38 43.64 ± 4.21 p=0.54  
6-week Symptoms 21.66 ± 0.86 21.88 ± 4.74 p=0.48 
Expectations 9.81 ± 0.52 
 
9.62 ± 0.56 
 
p = 0.01 









63.22 ± 1.81 65.30 ± 1.95 p= 0.443 
3-month 
 
Symptoms 22.97 ± 0.873 22.88 ± 0.74 p=0.30 
Expectations 10.15 ± 0.58 10.11 ± 0.567 p=0.15 
Satisfaction 30.08 ± 1.59 27.38 ± 1.71 p= 0.26 
Functional 
Activity 




64.20 ± 2.99 65.92 ± 2.16 p=0.18 
 
6.3.10 Adverse Events and Complications:  
Throughout the course of the trial adverse events and complications were 
recorded during patient’s in-hospital stay and follow-up interviews. There was a total of 
eight significant adverse events that caused a delay in discharge, three in the MSNB 
group and five in the LIA and infusion group (table 15).  
Table 15: Significant adverse events during study period 
Complication Group Treatment Delay in Discharge 
Foot drop MSNB Block cessation 1 day 
Foot drop LIA and Infusion Block cessation 1 day 
Quadriceps 
Weakness 





LIA and Infusion Block cessation 4 days 
Pulmonary 
Embolism 
MSNB Therapeutic Anticoagulation 3 days 
Catheter Site 
Abscess 
LIA and Infusion Spontaneous drainage, no 
septic arthritis 









LIA and Infusion Supportive management No delay 
 
Inadequate analgesia was the cause for delayed discharge in three MSNB patients 
(range, 1-2 days), and two LIA and infiltration patients (range, 1-4 days). Other 
complications were less debilitating and did not inhibit discharge. In the MSNB group, 
one patient’s block catheter occluded with blood, one patient’s catheter was accidentally 
dislodged from the entry site during physiotherapy, and one patent’s catheter leaked 
significantly. The management for each of these was early block removal and 
conversion to oral analgesia. In the LIA and infusion group 14 patients had at least one 
catheter occlude with blood, three patients had significant leaking at catheter sites, and 









7 Discussion  
The purpose of this randomized control trial was to assess whether periarticular 
infiltration and infusion has a comparable time-to-discharge, analgesic quality, and 
complication rate to motor-sparing nerve blocks (MSNB) in patients who have 
undergone primary total knee arthroplasty. Interim analysis demonstrated no significant 
difference between the two groups in terms of the primary outcome of time to discharge 
from hospital (p=0.47). The mean time to discharge for MSNB and periarticular 
infiltration and infusion was 2.57 days (SD ± 1.0) and 2.5 days (SD ± 1.25) respectively. 
Current studies comparing continuous peripheral nerve blocks with intra-articular 
infusion are limited, but the literature supports this finding. Beausang et al. randomized 
96 patients to two study groups, continuous adductor canal block (n=50) and 
intraarticular catheter infusion (N=46) 134. They failed to demonstrate any significant 
difference between groups for length of stay in hospital (mean: 1.8 days for both 
groups). In a meta-analysis of 10 studies involving intra-articular catheters, Sun et al. 
found no statistical difference in the length of stay length of stay compared to placebo 
81.   
Regarding our secondary outcome measures, there were no overall significant 
differences in visual analogue scale (VAS) pain scores at rest or with activity. Similar to 
our previous study 12, MSNB provided a significant decrease in early pain scores. 
MSNB provided superior analgesia at 6-hours post-op during rest and activity as well as 
the afternoon of post-op day one during activity. On the morning of post-op day 2, there 
was a significant difference in pain scores during activity that in contrast favored 
periarticular infiltration and infusion. Peripheral nerve block studies are notoriously 
difficult to compare, as their results rely heavily on a number of variables including 
insertional technique, block location, anaesthetic drug choice, concentration and 
infusion rate, as well as analgesic adjuncts 81,93. Despite this, Beausang et al. found a 
similar result in that their adductor canal block group had significantly lower pain scores 
(3.60 ± 2.2 vs 4.38 ± 2.4, p= 0.02) early on prior to activity (physiotherapy) compared to 
continuous intraarticular infusion. Following the first data collection point, there were no 
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statistically significant differences in pain scores during and after activity 134. In our 
previous study, MSNB also had statistically significant lower pain scores early on at 2- 
and 4-hours post-op with activity, and 2 hours post-op at rest 12.  
The MSNB in our study is a modification of a standard adductor canal block to provide 
more posterior and lateral knee anaesthetic coverage as the knee is innervated by both 
the lumbar plexus (femoral and obturator nerves anterolaterally) and sacral plexus 
(sciatic nerve posteriorly) 22,135.  Adductor canal blocks have shown to be a reliable 
method of analgesia following total knee arthroplasty and provide the option of an 
indwelling catheter to prolong the block effect and decrease narcotic consumption 
24,80,90,136,137. Additionally, they have less risk of inhibiting quadriceps motor function and 
promote early ambulation in comparison to other more proximal regional methods such 
as epidural catheters and femoral nerve blocks 15,90,93,118. With MSNB, placement of a 
perineural indwelling catheter provides the option to prolong the anaesthetic effect of 
the block through bolus or continuous dosing of local anaesthetic 80. A substantial 
amount of evidence highlighting the potential benefits of continuous blocks exists, but 
few studies have compared single-injection adductor canal blocks versus a continuous 
technique directly.   
Shah et al. performed a randomized control trial comparing single-injection versus 
continuous adductor canal blocks analgesic efficacy, early patient ambulation and 
functional recovery, as well as opioid consumption 135. They found that the continuous 
group had statistically significant lower VAS pain scores at 4, 8 ,12, and 24 hours post 
op (p<0.001). There was also a significant difference in pain scores favoring the 
continuous block group at rest and activity on post-op day 1 and 2 (p<0.001). Two 
patients in the single-injection group required rescue opioid analgesia and none in the 
continuous group, which was consistent with other studies 92. The results supported the 
notion that continuous infusion extended the effect of peripheral analgesia compared to 
a single- injection technique.  
One would expect this outcome, as intuitively, having the ability to deliver more 
anaesthetic over time should yield a longer duration of analgesia. However, the results 
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comparing single-shot and continuous adductor canal blocks have been inconsistent. 
Zhang et al. performed a randomized, placebo-controlled trial comparing single-shot 
adductor canal block, continuous adductor canal block and a saline control group 120. 
The primary outcome was visual analogue scale for pain during activity. When 
comparing the two adductor canal block groups, single- injection versus continuous, 
they found no differences in any outcome measures except procedural time (single-
injection; 4 ± 1.4 minutes versus continuous; 20 ± 5.0 minutes) and complications. The 
continuous group had a vascular injury at the time of catheter insertion and one catheter 
accidentally dislodged from its insertion site. Considering the similar outcome 
measures, extra time involved to place the catheter, catheter cost, as well as increased 
risk of complications in the continuous group, they recommended using a single-
injection technique for adductor canal blockade 120.  
Bingham et al. performed a systematic review and meta-analysis of randomized 
controlled trials comparing single-injection to continuous peripheral nerve block 
techniques. They extracted data from 21 trials concerning pain scores, narcotic 
consumption, satisfaction and adverse effects. What was found was continuous 
peripheral blocks provided a significant decrease in pain scores on post-operative day 
zero (day of surgery) (p=0.005), one (p<0.001) and two (p<0.001). Patients who had a 
continuous block had significantly decreased narcotic intake and nausea symptoms and 
had higher overall patient satisfaction scores 92.  
Though continuous techniques possess these appealing qualities, there are still several 
factors that inhibit their wide-spread implementation. Nerve blocks are carried out prior 
to surgery and require resources such as regional block specialists, dedicated space, 
and ultrasound that add to the overall treatment cost. It isn’t without its risks either, with 
procedure specific complications including nerve injury, dense motor blockade, and 
catheter site complications 89,90,93.   
Peripheral nerve blocks target a specific nerve branch proximally to anaesthetise its 
sensory distribution distally, while periarticular infiltration works by essentially flooding 
the tissue with anaesthetic and inhibiting the nerve fibres surrounding the surgical site. 
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Periarticular infiltration is an easy, safe, and effective analgesic modality for the 
management of post-op pain following TKA 17,103. It possesses several similar qualities 
to MSNB such as maintenance of quadriceps function, promotion of early mobilization, 
and reduces opioid consumption without the additional resources and cost associated 
with MSNB and other peripheral blocks 12,17. The issue that arises with periarticular 
infiltration is the reduced duration of analgesia, as a one-time dose of anaesthetic is 
delivered at the end of the surgical procedure 81,138. In our previous study, Sogbien et al. 
demonstrated that a single-injection technique with MSNB provided significantly longer 
duration of analgesic effect, with a mean difference of 8.8 hours (95% CI= 3.98-13.62 
hours, p<0.01) compared to periarticular infiltration 12. Previous studies have found the 
duration of analgesic effect for periarticular infiltration to be variable and range 
anywhere from 8 to 48 hours 81. Though effective, this method does not lend itself to 
easily be transitioned to a continuous regional technique as anaesthetic distribution 
needs to be diffuse to be effective. Several studies have explored the idea, utilizing a 
variety of anaesthetic drug combinations, infusion rates, and procedure techniques with 
variable results 81,125.  
Ali et al. conducted a randomized control trial comparing intraarticular catheters in 200 
patients undergoing total knee arthroplasty 110. Ropivacaine was infused intraarticularly 
in the experimental group, while saline was used in the control group. Intra-operatively, 
both groups received periarticular infiltration with a drug cocktail of ropivacaine, 
ketorolac and epinephrine. Though not specifically stated in their paper, they were 
comparing a single dose infiltration technique with a continuous intra-articular infusion. 
Their primary outcome measure was VAS score for pain. The results of their study 
yielded that continuous intraarticular infusion only provided a statistically significant 
decrease in pain scores on post-op day one (12pm; p=0.02, 8pm p=0.03). Thus, 
continuous infusion did not extend the duration of analgesia as significantly as they had 
hypothesized 110.   
Sun et al. performed a meta-analysis of 10 clinical trials utilizing intra-articular infusion 
catheters versus placebo in 735 patients 81. Outcomes that were assessed were VAS 
scores a rest and activity at 24, 48, and 72 hours post-op, duration of surgery, length of 
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stay in hospital, and complications. Their resulted revealed that continuous intra-
articular infusion provided statistically significant decrease in VAS pain scores at 24 
hours during rest (p<0.01) and activity (p<0.01) and with activity at 48 hours (p<0.01). 
There was no difference between groups in regard to pain at rest at 48 hours as well as 
during rest and activity at 72 hours. The duration of surgery and the length of stay in 
hospital was also similar between groups.    
Similar to adductor canal blocks, high quality randomized controlled trials directly 
comparing single-dose periarticular infiltration to continuous intraarticular are scarce. 
Zhang et al. randomized 80 patients to three different treatment groups, single-dose 
periarticular infiltration, continuous intra-articular infusion, and saline control group 138. 
The primary outcome was VAS pain scores over 48 hours post-op. The analysis 
revealed that VAS scores were lower in the continuous infusion group compared to the 
single-dose infiltration group and were statistically significant at rest (p<0.05) from 8 to 
48 hours post-op and during activity (p<0.05) from 16 to 48 hours post-op. Morphine 
consumption was significantly higher in the single-dose infiltration group (p<0.05). 
Maximum knee flexion at 7-and 90-days post-op was significantly increased in the 
continuous infusion group as well (p<0.05) 138.  
Narcotic consumption was not significantly different between our experimental and 
control groups at any of the post-operative inpatient time points (p= 0.59). Periarticular 
infiltration and infusion consistently required more narcotic rescue analgesia compared 
to MSNB, but it was not significant (Table. 3). Our previous single- dose study 
demonstrated no significant difference in opioid consumption as well, but narcotic intake 
was nearly the same at all time points between groups 12. Our results reflect those 
found by Beausang et al. 134.  When comparing adductor canal blocks to Intra-articular 
infusion, they found opioid consumption in morphine equivalents was not statistically 
significant at 24 (p=0.057) and 48 hours (p=0.106) post-op between groups. Similar to 
our study, they also observed that the total opioid consumption in the adductor canal 
block group was less than that of the intra-articular infusion group 134.  
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Nausea is a common side effect as a result of narcotic use and was quantitatively 
assessed using a 0-4 numeric scale (0=none, 1=mild, 2=moderate, 3=severe, 4= 
extreme) 75. There was not a significant overall difference in nausea scores during the 
6-day assessment period (p=0.21) similar to our previous study 12. Previous studies 
have demonstrated that continuous analgesic methods may decrease nausea 
symptoms compared to single-shot techniques or placebo 80,81,90,138. This may be due to 
the prolonged analgesic quality of the continuous blocks and results in less narcotic 
consumption 75.   
Respiratory depression is a risk with large quantities of narcotics and so patient vitals 
were collected at each post-operative timepoint to ensure there were no significant 
respiratory side effects went unobserved 75. There were no statistically significant 
differences in respiratory rate (p=0.54) and oxygen saturation (p=0.67) between groups 
during the inpatient stay.  
Post-operative function was evaluated by assessing ability to perform physiotherapy at 
each time point as well as range of motion achieved. There were no significant 
differences between groups in ability to perform physiotherapy (p=0.49) as well as no 
differences in first flexion angle achieved (p=0.23) and best flexion angle achieved 
(p=0.15) while in hospital. Again, this was similar to what Sogbein et al. observed when 
no significant differences were found in patient’s eligibility to perform physiotherapy or in 
time and length of first mobilization 12. When assessing range of movement between 
groups, Beausang et al. also demonstrated no difference in active range of movement 
between groups at any of their assessment time points 134.  
Regarding our patient reported functional outcome scores, there were no significant 
differences in the pre-operative and 3-month SF-12, WOMAC, or KSS outcome scores. 
This is consistent with our previous study and as well as the results published by 
Beausang et al. 12134. Interestingly, there was a significant difference in the KSS 
expectations section of the questionnaire at the 6-week post-operative mark favoring 
the MSNB group, but is unlikely to be clinically relevant and was balanced by 3-months 
post-op. Our results demonstrated an improvement from pre-op scores for pain, 
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stiffness, mental and physical health, and function at the 3-month mark across both 
groups and was not significantly different between groups (Table 5, Table 6, Table 7).  
The heterogeneity that is present across continuous peripheral nerve block and infusion 
studies inevitably makes it challenging to make generalizations on complication rates 
associated with these procedures, but there are some consistencies in the literature.  
Largely, the risk of quadriceps weakness in adductor canal blocks is less compared to 
that of other regional techniques, though it still can occur 139. In our study, one MSNB 
patient and one LIA and infusion patient suffered a delay in discharge of 2 and 4 days 
respectively due to quadriceps weakness. One patient in each group also suffered a 
transient foot-drop that resulted in a 1-day delay in discharge each. Though we could 
not find dense motor blockade as a previously described complication of periarticular 
infiltration, we suspect it occurred due to inability to direct infusion flow through the 
catheters and enough volume collected anteriorly and posteriorly to cause the adverse 
effect. All four patients suffered only transient loss of function and were discharged once 
their motor control returned.  
The major concern with periarticular infusion catheters is the theoretical increased risk 
of prosthetic joint infection. Several studies have reported conflicting results. A meta-
analysis of seven studies (579 patients) utilizing continuous intraarticular catheter 
infusions found there to be a significant increase in the rate of infection (relative risk 
[RR] 3.16, 95% CI 1.18-8.50, p=0.02) when compared to placebo 81. These studies had 
small sample sizes though and only three of the seven reported infection occurring in 
the catheter group. A second metanalysis by Zhang et al. re-analyzed 6 of the 7 studies 
in the previous analysis and reiterated these results, finding a statistically significant 
difference in infection risk with intra-articular catheters (relative risk [RR} 3.45, 95% CI 
1.16-10.33, p= 0.03) 125. Of the 7 studies included across both meta-analyses, only one 
study was found to have a significant difference between groups in regard to infection. 
Ali et al. reported a significant difference (p=0.02) between groups at 3-month post-op, 
with 11 cases of infection in their intervention group (ropivacaine) and two cases in their 
control group (saline). Six of these cases were deep infections (five from the 
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intervention group) and all required surgical intervention. It should be noted though that 
their control group also had an intra-articular catheter in situ infusing saline. The risk of 
external contamination was still present, and thus they weren’t able to fully explain why 
such a significant increase in infection occurred in their intervention group.  
In contrast, during our assessment period there were no infections within the three 
months following surgery in either group. One LIA and infusion patient developed 
prolonged drainage from the site of the posterior catheter during the first two weeks 
post-op but did not require intervention. Similarly, Zhang et al reported no infections at 3 
months post-operatively in either of their intervention groups 138. Ham et al performed a 
large retrospective-analysis of 1915 patients at a single center to determine the rate of 
deep infection in patients who had received an intraarticular catheter. There was no 
statistically significant difference (in the deep infection rate, with the rate in intra-articular 
catheters being 0.53% as opposed to 0.77% in patients who did not receive a catheter 
140. Other randomized controlled trials have reiterated these results, finding no 
statistically significant difference in infection rate with intra-articular catheters 107,109. 
Interestingly, local anaesthetics have demonstrated antimicrobial effects that may help 
counteract the increased risk of contamination through the intra-articular catheter 141.  
Deep prosthetic joint Infection is a potentially serious complication that is unique to 
intraarticular catheters. Due to the relatively short follow-up period and small sample 
sizes in our own study as well as in the current prospective literature, further 
investigation is needed to define the true risk of Infection 81.  
Another concern involving continuous infusions is the risk of local anaesthetic systemic 
toxicity. Symptoms of toxicity include circumoral numbness, metallic taste, pruritis, to 
more severe complications such as cardiac arrhythmias, cardiac arrest, seizures, 
respiratory arrest, and coma 89,93. One patient in the LIA and infusion group suffered 
from local anaesthetic toxicity that was managed through block cessation and 
supportive treatment. Due to the heterogeneity in peripheral anaesthetic drug types, 
concentrations and infusion rates, no optimal infusion protocol has been identified 81,90. 
Fortunately, anaesthetic toxicity is rare 80. Sites et al. performed a retrospective review 
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of 12,668 patient who received ultra-sound guided nerve blocks and found the rar e to 
be 1.8 per 1000 blocks performed (CI 95%, 1.1-2.7) 94. Several prospective randomized 
control trials assessing both perineural catheters as well as intra-articular catheters 
have also found this to be true, reporting no cases of local anaesthetic systemic toxicity 
in research subjects. 107,134,135. Bleckner et al. investigated ropivacaine serum levels in 
trauma patients who received long-term peripheral anaesthetic infusions at high doses 
142. The median duration of perineural catheter infusion was 7 days (range: 2-23 days) 
with a median dose of 3722mg (range: 1146mg - 22,320mg). Despite the large doses 
incurred by some patients, ropivacaine serum free concentrations remained below toxic 
levels in all patients throughout the study and demonstrated a favorable safety profile 
for these analgesic techniques 142.  
A number of mild adverse events occurred during the study period that have been 
previously described as potential problems with both intra-articular catheters as well as 
continuous nerve blocks.80,81,89,93. These include catheter occlusion, leakage, and 
dislodgement. In our trial, catheter occlusions were documented when failure to 
establish patency with a saline flush occurred. There was one case of catheter 
occlusion in MSNB group, where in periarticular infiltration and infusion group, 14 
patients had at least one catheter occlude with blood. The reason for such a significant 
difference was not unexpected, as there are three points of possible occlusion in the LIA 
and infusion group and no control over the direction of infusion flow as it travels in the 
path of least resistance. The haemarthrosis that forms following surgery also 
predisposes the intraarticular catheter to occlusion. This may have affected the early 
analgesic quality resulting in a significant difference in early rest and activity visual 
analogue scores.  One MSNB patient’s catheter and two LIA and infusion catheters 
were accidentally dislodged from the entry sites during physiotherapy. There was one 
case of significant catheter site leakage in the MSNB group and three in the LIA and 
infusion group. The management for each of these was early block removal and 
conversion to oral analgesia. A complication described in the literature is retained 
portions of the indwelling catheter 134. No cases of catheter retention occurred 
throughout the study period.  
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7.1 Study strengths  
The strengths of our study begin with our conservative patient eligibility criteria to 
allow for as much internal and external validity in our results as possible. We strived to 
have the study sample represent the real-world population as best as possible while 
trying to remove some confounding variables such as pre-operative narcotic use and 
chronic pain. Our study utilized randomization to reduce our risk of selection bias, as 
well as control for unknown confounders. We used a single investigator to collect data 
at various time points rather than multiple inpatient care providers to increase the 
reliability of our data. Our experimental group utilized a unique three catheter 
arrangement not previously described in the literature in an effort to provide a more 
diffuse analgesic coverage comparable to MSNB. Few studies exist comparing 
continuous wound infusions with other peripheral nerve blocks, and we aimed to 
contribute to the current literature by comparing these two different regional anaesthetic 
approaches.  
 
7.2 Study Limitations  
This randomized-control study has a number of limitations that were discovered 
throughout the trial. The first limitation is the incomplete data and quoted results from 
the preliminary analysis. The reasons for this are that enrollment was not completed at 
the time of analysis, with 16 patients still required to reach study power, as well as the 
unfortunate timing of a nationwide shortage of ropivacaine that placed the study on a 
long hiatus. Thus, definitive conclusions on the primary outcome cannot be made from 
the data. The study was powered to find statistically significant differences in time to 
discharge from hospital. None of the secondary outcomes were factored into the power 
analysis and thus no definitive conclusions of the secondary outcomes can be made 
from the data upon completion. Another limitation is the small sample size, which lends 
itself to more variability and the chance of the study sample not being truly 
representative of the population.  
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Though the study was randomized using blocked random number sequence generation, 
there was a risk of selection bias occurring due to method of allocation concealment. 
Random number sequence generation was performed by an independent party, but 
envelop concealment was utilized for group allocation with a small blocking group of 
five, opening up the possibility the investigator could anticipate assignments.  
The lack of blinding in our study patients, providers, assessors and analyzers puts the 
study at risk for potential biases. There was a risk of response bias due to patients 
having the knowledge they are in the control or experimental group and falsely inflate or 
deflate their responses for a number of reasons including their previous experience, 
their personality, and their relationship with the assessor. There was also a significant 
risk of performance and detection bias due to the lack of blinding of participants, 
personnel, and assessors as the outcome of pain is highly likely to be influenced by 
knowledge of the treatment group. Expectation bias is also a possibility with patients 
expecting have a greater improvement in pain with the use an experimental treatment 
(periarticular infiltration and infusion) versus standard methods. This increases the 
experimental treatment response and decreases the signal detection between the two 
treatment groups.  
Though both treatments continuously delivered anaesthetic, there were some 
unavoidable inequalities. In the MSNB group, there is less procedural variability as a 
single catheter is accurately placed under ultra-sound guidance, decreasing the 
likelihood of block failure. In periarticular infiltration and infusion, there are three 
catheters, with one being placed posteriorly without ultrasound guidance. These 
catheters had less precise placement in comparison to the MSNB and direction of 
infusion flow was not controllable, taking the path of least resistance between the three 
catheters. Though there was not an overall significant difference in pain scores in the 
interim analysis, these discrepancies could add to the explanation as to why MSNB 
demonstrated superior early analgesia at rest and with activity and are a limitation.  
We did not collect blood samples to assess for serum ropivacaine levels and is a 
potential limitation in our study. Though we only had one documented symptomatic 
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event of anaesthetic toxicity, we are not able to comment on if other patient’s blood 
levels reached toxicity and were asymptomatic with the high infusion rate (8ml/hr) and 
volume we were using. 
Another limitation of our study involves the data collection time points. Patients had 
variable operative times on the day of surgery, and thus having fixed data collection 
points (9am and 2pm on each post-operative day) meant some patients were assessed 
earlier or later depending on their time of surgery. This could affect secondary outcomes 
measures including pain scores, ability to perform physiotherapy, and narcotic 















8.1 Clinical Relevance  
The goal of our randomized control trial was to assess whether periarticular 
infiltration and infusion has comparable clinical and functional outcomes to that of 
motor-sparing nerve blocks in patients who have undergone primary total knee 
arthroplasty. The use of motor sparing nerve blocks for analgesia following TKA has 
been supported through our previous work as well as the existing literature. Though it is 
an effective treatment, it is not a feasible option for the majority of orthopaedic surgeons 
that perform knee replacements, especially in community settings. The additional skills 
and cost required to provide nerve blocks consistently to patients make them difficult to 
implement in a resource constrained health care system. It is our duty as a larger 
tertiary center to explore continuous regional anaesthetic options that are comparable to 
our standard of care and can realistically be adopted by our colleagues who don’t have 
access to such analgesic options. A practical anaesthetic technique needs to be 
relatively inexpensive, encourage narcotic stewardship, promotes early ambulation so 
as not to delay discharge, and not have a significant increase in complications such as 
infection, dense motor blockade, or a high rate of failure. Our interim analysis supports 
this effort thus far by yielding non- significant results between our experimental and 
control groups for our primary outcome of time-to-discharge, pain scores at rest and 
activity, narcotic consumption, as well as patient reported functional outcomes.  
 
8.2 Future direction  
Our future direction for the study is to finish enrollment and the trial and continue 
to explore the application of periarticular infiltration and infusion in patients undergoing 
primary total knee arthroplasty. We plan to perform a retrospective review of study 
patients to assess for late complications such as prosthetic joint infection that could be 
associated with periarticular infiltration and infusion and determine if it is a significant 
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risk. Cost effectiveness analysis is also a future plan, as we must provide evidence that 
periarticular infiltration and infusion doesn’t significantly add to the overall cost of the 
procedure, while being a less expensive modality than motor-sparing nerve block. We 
will then explore the interest in peripheral centers for such a treatment option and assist 
in its implementation into their post-operative care plans. A potential future study for 
periarticular infiltration and infusion will be its roll in out-patient analgesia for same-day 
or fast-tracked discharge following total knee arthroplasty by allowing patients to be 
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17 October 2017 Page 1 of 7 _______________  
     Participant’s Initials 
 
Letter of Information and Consent Form 
 
Outcomes after Total Knee Joint Arthroplasty: A comparative study using 
different analgesic techniques 
 
 
Principal Investigator     Research Assistant 
Dr. James Howard   519-663-3551  Dr. James Allen 519-685-8500 x34568 
 
Co-Investigators  
Dr. Brent Lanting  519-663-3335  Dr. Sugantha Ganapathy 
Dr. Edward Vasarhelyi  519-663-3413  Dr. Mahesh Nagappa 
Dr. Peter Mack     Dr. Deepti Vissa 
 
You are being invited to voluntarily participate in a research study conducted by the Department 
of Orthopedic Surgery and Departments of Anesthesiology and Perioperative Medicine at the 
University of Western Ontario. As a patient scheduled to have a Total Knee Replacement (TKR), 
we invite you to consider taking part in this research study. This letter of information describes 
the research study and your role as a participant. Please read this letter of information carefully. 
Do not hesitate to ask anything about the information provided. Your surgeon, anesthesiologist 
or the study coordinator will describe the study and answer your questions. Your decision is 
completely voluntary and will not affect your medical care if you choose not to participate. You 
may take as much time as you need to decide whether to participate and can discuss participation 
with your friends, family, family doctor, etc. 
 
WHY ARE WE DOING THIS STUDY? 
 
The operation you will be having (Total Knee Replacement, shortened to TKR) is a very 
common one. However without proper treatment the first 2 to 3 days after the operation can be 
very painful. There are several different options for providing pain relief while you are in 
hospital after a TKR. 
 
The current methods to control pain following knee surgery in our hospital include oral 
medications combined with either nerve block or wound infiltration with freezing agent. A nerve 
block is an anesthetic injection (freezing) targeted toward a certain nerve or group of nerves to 
treat pain. The purpose of the injection is to "turn off" a pain signal coming from a specific 
location in the body (in your case the knee). Ultrasound is used to help the doctor place the 
needle in exactly the right location so that you can receive maximum benefit from the injection. 
Sometimes, these nerve blocks can make your leg weak with a potential for you to fall down. 
Performing these blocks in the mid-thigh level can minimize leg weakness while providing good 
quality pain relief. Usually a tiny tube (block catheter) is placed close to the nerve carrying 
sensation from the knee joint which is connected to a pump delivering freezing around the same 
nerve. These nerve blocks are continued after surgery so that the surgical wound is frozen as 
long as the blocks are in place. Alternately, the surgeon may insert tiny tubes around the joint at 
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tubes are connected to a balloon pump delivering freezing directly into the wound. Along with 
the nerve blocks or freezing around the joint, you are provided with oral medications for pain 
relief. The pain management techniques performed as a part of the study are commonly offered 
to all patients undergoing TKR. 
 
With all these measures, a healthy individual without any major medical or surgical problems 
should be able to do physiotherapy exercises with well controlled pain following the surgery. If 
you can achieve the rehabilitation goals (do the physiotherapy exercises) within the first day 
following surgery, you may be suitable to be sent home while continuing the same pain 
management measures.  
   
The aim of this study is to determine the effectiveness and safety of the different pain-relieving 
techniques. 
  
WHAT DOES THE STUDY INVOLVE? 
 
If you are eligible and agree to participate in the study, you will be randomized, like the flip of a 
coin, to one of the two pain treatment groups during your visit to the preadmission clinic. To 
provide anesthesia during the operation you will receive a spinal anesthetic. This will numb the 
entire lower half of your body for about 4 hours.  The group you are randomized to will 
determine the method of postoperative pain relief. Your surgical procedure will not be changed 
as a result of your participation in the study. 
 
Group 1: Patients in this group will receive what are known as ‘motor sparing nerve blocks’ 
before the operation.  This involves numbing the 2 nerves, which supply the bulk of the 
sensation to the knee.  A small plastic tube will be inserted close to the nerves supplying the knee 
joint combined with injecting freezing behind the knee using an ultrasound. The anesthetic 
doctor will explain the details of the procedure to you. Dilute local anesthetic (freezing) is 
delivered via these tubes until discharge, keeping the operated knee numb during that period.  
 
Group 2:  This group will receive freezing solution injected into the wound at the end of surgery 
by the surgeon. The surgeon will leave 3 very fine tubes inside the wound just before it is closed.  
During the two days after the operation very small amounts of freezing solution will be delivered 
through these tubes into the wound, in order to numb the knee. 
 
You will receive multiple oral pain killers called multimodal analgesia starting in the 
preoperative period as needed according to the standard of care for University Hospital. This 
will allow your pain to be managed better. 
 
Following the operation you will be followed up closely until you are discharged from hospital.  
You will be assessed on a regular basis for any pain, feelings of nausea or sedation, and how you 
are progressing with your physiotherapy. All participants will be assessed for discharge criteria 
by the research staff 6 hours after surgery and twice daily until discharge. If you meet the 
discharge criteria and maintain it at the next evaluation, your indwelling anaesthetic tubes will be 
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The discharge criteria include satisfaction of the first four of the five criteria: 
 
1. You should be able to take care of personal care, get in and out of bed, into and up from a 
chair, on and off a toilet and to walk with proper walking aids 70 m without time limit; 
ability to do five steps. 
2. Free of medical or surgical complications including urinary catheterization or need for 
blood transfusion 
3. Acceptable pain relief (NRS ≤ 5/10) without any need for intravenous analgesics. 
4. No nausea/ vomiting; generalized weakness or dizziness. 
5. Knee flexion of 900 is optional but preferred. 
 
A pain diary will be given to you before you are discharged to record your pain, the degree of 
knee movement, the success of physiotherapy, any feelings of nausea or sedation, post-operative 
complications, and the amount of pain killers that you have taken twice daily. You will be asked 
to complete this diary for 4 days after you are discharged from hospital. You will be educated on 
how to complete your post-operative pain diary before you leave the hospital. Research staff will 
call you at home on days 1 and 4 after you have been discharged from hospital to answer any 
questions you may have about the pain diary. This diary will be returned to the research staff at 
your next appointment with your surgeon (at 2 weeks after surgery). 
 
Reasons for delay in discharge will be collected. The research team will obtain data regarding 
any complications that you may develop while you are in the hospital from the hospital chart, 
and any that develop after discharge by talking to you and your surgeon at each of your standard 
follow-up appointments in clinic. Any complication that you may develop will be managed as 
per the standard practice at London Health Sciences Centre.  
 
You will be asked to complete 3 questionnaires (SF-12, WOMAC and Knee Society Score) at 
your preadmission appointment before surgery and at 6 weeks and 3 months after surgery. These 
questionnaires ask about your general health, pain and function. At your 2 week visit to clinic, 
the research staff will measure the range of motion of your knee and ask about your pain. There 
are no extra visits required as part of this study. Follow-up appointments at 2 weeks, 6 weeks and 




Regional nerve blocks have been shown to be a very safe alternative to general anesthesia.  
However, just as general anesthesia carries risks, regional anesthesia entails certain risks too.  
Serious risks are very rare, but they are of a different nature to those of general anesthesia and 
the risks are detailed below.  The numbers below indicate the risk of each problem.  For example 
1/10,000 means on average 1 in every 10,000 patients undergoing a nerve block will suffer that 
problem. 
 
1. Failed block:  The block may provide inadequate pain relief. This occurs in 5/100 to 
10/100 of patients.  If this occurs, alternative oral or intravenous medications such as 
morphine or dilaudid will be used to make you comfortable. 
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3. Temporary nerve irritation leading to an area of numbness or tingling persisting for up to 
a week – 1/100 
4. Risk of suffering a temporary seizure due to the local anesthetic being too rapidly 
absorbed – very rare.  1/10,000 to 1/100,000. 
5. Risk of suffering longer-term nerve damage lasting several months – very rare.  1/5000 to 
1/10,000. 
6. Risk of suffering permanent nerve damage – very rare – 1/100,000,000. 
 
Side effects from the sedation include short-term (a few minutes to a few hours) drowsiness, 
forgetfulness and sometimes minor temporary itching. 
 
Wound infiltration and infusion of local anesthetic may be associated rarely with toxicity from 
absorbed local anesthetic, nerve injury and infection. The exact frequency of these problems is 
currently unknown. 
 
A member of the research team will explain all the details during your visit to the preadmission 
clinic. 
 
EXPECTED DURATION OF THE STUDY AND NUMBER OF SUBJECTS EXPECTED 
TO PARTICIPATE 
 
There will be about 70 people in this study, which will be conducted at University Hospital, 
London.  The study is expected to run for one year; however your participation is expected to last 
3 months (from surgery until your 3 month follow-up appointment). 
 
STUDY RESTRICTIONS/PARTICIPANT RESPONSIBILITIES 
 
As a participant in a research study, you have certain responsibilities.Your responsibilities are to: 
 
1. Follow procedures as instructed 
2. If possible, answer the study related questions asked by the research team 
3. Report all changes in your physical or mental condition during the course of the study, 
whether or not you feel they are related to the study procedures 
 
The study doctor has the right to stop your participation in the study at any time, with or without 
your consent, if he or she feels that this is in your best interest. 
 
The study or part of the study may be stopped at any time at the discretion of your study doctor, 
or the University of Western Ontario Health Sciences Research Ethics Board. 
 
Tell a study doctor immediately if you have a side effect from the treatment. 
 
All female patients in the childbearing age group not practicing acceptable methods of 
contraception will have a urine pregnancy test done on the morning of surgery. Subjects who test 
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BENEFITS 
 
Participation in this study may or may not be of a direct benefit to you. It is possible your pain 
relief may be better as you will be very closely monitored while you are in hospital. 
 
ALTERNATIVES TO STUDY PARTICIPATION 
 
If you decide not to participate in this study it will NOT prejudice your care.  After discussion 
with your anesthesiologist you will receive the most appropriate anesthetic which will suit you 




Your participation in this study is completely voluntary. You may refuse to participate, refuse to 
answer any questions or withdraw from the study at any time with NO effect on your future care. 
You do not waive any legal rights by signing the consent form. 
 
PRIVACY AND CONFIDENTIALITY 
 
All records compiled during this study in which you are identified will be kept confidential, and 
will not be disclosed outside the research group except as required by law and as described 
below. 
 
Tests and procedures done solely for this research study may be placed in your medical record to 
indicate your participation in this study. Upon completion of the study, you may have access to 
the research information if contained in the medical record. 
 
Representatives of the University of Western Ontario Health Sciences Research Ethics Board 
may contact you or require access to your study-related records to monitor the conduct of the 
research. You do not waive any legal rights by signing the consent form. If you choose not to 
sign the consent form, you will not be included in this research study. You may choose to 
withdraw from the study even after consenting for the participation in the Study. If you choose 
not to sign the consent form, you will not be included in this research study. 
 
RESEARCH RELATED INJURY 
 
If physical injury occurs due to your involvement in this research, medical treatment will be 
available to you as per the standard care at our institution provided by OHIP. Compensation for 




There will be no additional costs to you as a result of being in this study. You will not be 
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CONTACT FOR QUESTIONS 
 
Before you sign the consent form, you should ask questions about anything that you do not 
understand. The study staff will answer questions before, during, and after the study. 
 
If you have questions about this study or how it is being run, you should contact Dr. James 
Howard, the principal investigator at 519-663-3551, or the research assistant, Dr. James Allen at 
519-685-8500 x34568 at London Health Sciences Centre, University Hospital. If you have any 
questions about your rights as a research participant you may contact the Office of Human 
Research Ethics at 519-661-3036 or ethics@uwo.ca. 
 
In case of an emergency, please contact Dr. James Howard at 519-663-3551 OR go to the nearest 
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Consent Form 
 
Outcomes after Total Knee Joint Arthroplasty: A comparative study using 
different analgesic techniques. 
 
I have read the Letter of Information, have had the nature of the study explained to me and I 
agree to participate.  All questions have been answered to my satisfaction.  I will receive a copy 
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From: photiusc@gmail.com
Subject: Re: Photius.com Feedback
Date: 19 March 2019 at 06:56
To: James.Allen@lhsc.on.ca
Hello James Allen,
Thank you for your inquiry,
You are welcome to use the text and images, and we request that you acknowledge the source as:
"Source: theodora.com/anatomy, used with permission", and in case of online publication, that you also place a link to the site:
"Source: <a href="https://theodora.com/anatomy">theodora.com/anatomy</a>, used with permission".
Regards,
Photius Coutsoukis
OTHER ITA WEB SITES:
- Menu of ITA websites - STREET VIEWS
On Mon, Mar 18, 2019 at 9:46 PM World Wide Web Owner <www@pubweb-2.bestweb.net> wrote:











My name is James and I am a orthopaedic resident and current master's student at the University of Western Ontario. I am
currently writing my thesis titled "POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE ARTHROPLASTY: A
RANDOMISED CONTROL TRIAL COMPARING REGIONAL TECHNIQUES" and was wondering if I could kindly request the


















From: Daryl Goldman goldmadt@gmail.com
Subject: Re: Figure use for thesis
Date: 27 March 2019 at 10:15
To: James Allen James.Allen@lhsc.on.ca
Hey sorry,
It is fine as long as you get permission from the publisher. 
Thanks,
Daryl
On Wed, Mar 27, 2019 at 9:50 AM James Allen <James.Allen@lhsc.on.ca> wrote:
Hi Dr. Goldman,
Hope you are doing well. Any chance you have heard from your co-authors about the use of the image? I am terribly sorry for
the repeated messages and I know how busy you are. I appreciate your time!
 
Thanks,
Dr. James H. Allen
PGY1 Orthopaedic Surgery
Western University  
 
From: Daryl Goldman <goldmadt@gmail.com>
Date: Thursday 21 March 2019 at 16:39
To: James Allen <James.Allen@lhsc.on.ca>









On Thu, Mar 21, 2019 at 4:38 PM James Allen <James.Allen@lhsc.on.ca> wrote:
Hello Dr. Goldman,
My name is James Allen and I am an Orthopaedic Surgery resident at Western University, Ontario and a current Masters of
Surgery student. I writing my thesis currently on the subject of post-op pain control following total knee arthroplasty. The title
is “POST-OPERATIVE ANALGESIA FOLLOWING TOTAL KNEE ARTHROPLASTY: A RANDOMISED CONTROL TRIAL
COMPARING REGIONAL TECHNIQUES”. I was wondering if it would be possible to get your approval for the use of a
figure in a recent paper of yours, “Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain”,
specifically Figure 1 demonstrating the knee neuroanatomy as it is a fantastic image.
Its use would be in the literature review section and would be listed with a proper citation.




This email is directed in confidence solely to the person named above and may contain confidential,
privileged or personal health information. Please be aware that this email may also be released to
members of the public under Ontario's Freedom of Information and Protection of Privacy Act if
required. Review, distribution, or disclosure of this email by anyone other than the person(s) for whom




it was originally intended is strictly prohibited. If you are not an intended recipient, please notify the




Daryl Goldman, MD 




This email is directed in confidence solely to the person named above and may contain confidential,
privileged or personal health information. Please be aware that this email may also be released to
members of the public under Ontario's Freedom of Information and Protection of Privacy Act if required.
Review, distribution, or disclosure of this email by anyone other than the person(s) for whom it was
originally intended is strictly prohibited. If you are not an intended recipient, please notify the sender




Daryl Goldman, MD 







From: Oliver Jones oliver@teachmeseries.com
Subject: RE: New submission from Contact us



























	 Use of photo for thesis (TIME SENSITIVE)
Message
	
To Whom it may concern, 
My name is James Allen and I am a first year Orthopaedic Resident at UWO in Canada and a
masters student. I am writing to you with a request for permission for the use of one of your
photos, "Fig 1.0 – Cross-section of the thigh, showing the borders of the adductor canal. Note: the
adductor magnus is not visible in this illustration" on the adductor canal webpage. I am looking to
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James Hilliard Allen Curriculum Vitae 
 
Educational Background 
Orthopaedic Surgery Resident 2018-2023, Department of Orthopaedic Surgery, 
Schulich School of Medicine, Western University  
MB, BCh BAO (NUI, RCSI), LRCP&SI, Royal College of Surgeons in Ireland- 2010- 2016 
Six-Year Program. Graduated with Honours  
 
Certifications and Assessments:  
Advanced Trauma Life Support- June 2018  
Advanced Cardiac Life Support and renewal of Basic Cardiac Life Support- June 2018-
2020 
Standard First Aid & CPR- Basic Cardiac Life Support (BCLS)- June 2018-2020 
 
Research Experience:  
Surgeon Scientist Program: Schulich School of Medicine and Dentistry- Western 
University - September 2017-August 2019 
MSc Degree (candidate) 
Thesis title: Outcomes after Total Knee Joint Arthroplasty: A comparative study using 
different analgesic techniques 
Description: 
• Prospective randomized control trial  
• Assessing two possible local anesthetic modalities following unilateral Primary Total 
Knee Arthroplasty 
• Two groups include the control group, Motor Sparing Nerve block, and the intervention 
group, Local Infiltration anaesthesia plus periarticular infusion. 
• Collected data points include analgesic quality, side effects and complications, narcotic 
consumption, and functional outcomes preoperatively and postoperatively  
Required Courses:  
• Advanced Principles of Surgical Research  
• Advanced Surgical Research Colloquium  
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• Advanced Statistics and Research Methods for Surgeons 
 
Head Injury in Patients with Hip Fractures: A Retrospective Review  
• Data collection and second author roles 
• Assessing the indications and frequency of CT head scans in the hip fracture 
population 
• Assessing the appropriateness of the Canadian CT Head Rules/ New Orleans 
Criteria in this population  
• Poster presentation at the 2018 American Academy of Orthopaedic Surgeons and 
the 2018 Canadian Orthopaedic Association annual meetings 
• High scoring poster award at the Canadian Orthopaedic Association annual meeting 
 
Orthopaedic Research: Mount Sinai Hospital- University of Toronto- September 
2016-December 2017 
Revision Hip Arthroplasty long-term survivorship study using the Zimmer ZMR Modular 
Hip System  
Description:  
• Retrospectively reviewed 335 patients who received a Tapered or Porous ZMR 
femoral component between 1999 to 2006 at Mount Sinai Hospital  
• Follow-up studies conducted to reassess the same patient groups from previous 
mid-term survivorship papers from Mount Sinai published in 2010  
• Reviewed Tapered and Porous groups separately to assess follow-up and 
complications to determine rate of failure 
• Patients were contacted if digital records were inadequate 
• Harris Hip scores were obtained to determine post-operative functional outcomes   
• Follow-up radiographs were classified for component osseous integration and 
proximal bone stock by fellowship trained arthroplasty surgeons  
• Podium Presentation at the 2018 American Academy of Orthopaedic Surgeons and 




Rural Orthopaedic Surgery: Cape Breton Regional Hospital- November 2016  
Two-week elective with Dr. Kevin Orrell, former Canadian Orthopaedic Association 




• Operating Room privileges with hands-on participation in 15 cases  
• Clinic privileges using clinical knowledge to develop management plans for various 
Orthopaedic conditions 
• One-on-one teaching from consultant Orthopaedic surgeons  
• Further Rural medicine experience and understanding of the Nova Scotia 
Healthcare System  
 
Community Orthopaedic Surgery: Chatham-Kent Health Alliance- January 2016  
Three-week elective with Dr. John Turnbull   
Description: 
• Operating Room privileges participating in approximately 30 cases  
• Clinic privileges and further involvement as I was the only student 
• One-on-one teaching from consultant Orthopaedic surgeons  
• Full time on-call for the full elective period 
• Further Rural medicine experience and understanding of the Ontario Health System  
 
General & Orthopaedic Oncology Surgery: Dalhousie University- September 2015  
Two-week elective in Halifax Infirmary with Dr. Michael Biddulph  
Description: 
• Clinical elective including direct patient contact in clinical settings (in and out-
patients) 
• Operating room privileges observing and participating in approximately 30 cases  
• Attended all resident teaching sessions, on-call, and grand-rounds 
• Attended weekend-call while at Halifax Infirmary assisting junior and senior 
residents 
• Worked alongside final-year residents, fellows, and other visiting elective medical 
students in the clinics, operating room, and in-patient wards 
• Further development of Orthopaedic history taking and physical exam skills as well 
as obtaining more knowledge in establishing working differential diagnoses 
• Further knowledge into the potential treatment options of various Orthopaedic 
injuries, congenital skeletal defects, and reconstructive procedures 
• Development of the communication skills required to work in a cohesive surgical 
team 
 
Arthroplasty & Trauma Orthopaedic Surgery: Schulich School of Medicine  
and Dentistry- Western University - August 2015 
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Three-week elective with Dr. James Howard, participated in the operating rooms of Dr. 
Brent Lanting, Dr. David Sanders, as well as the out-patient clinics and operating rooms 
of Dr. Edward Vasarhelyi.  
Description: 
• Clinical elective including direct patient contact in clinical settings (in and out-
patients)  
• Operating room privileges observing and participating in approximately 30 cases  
• Attended all resident teaching sessions, on-call and grand-rounds 
• Worked alongside final-year residents, fellows, and other visiting elective medical 
students 
• Further development of Orthopaedic history taking and physical exam skills as well 
as obtaining more knowledge in establishing working differential diagnoses.  
• Further knowledge into the potential treatment options of various Orthopaedic 
injuries, congenital skeletal defects, and reconstructive procedures 
• Development of the communication skills required to work in a cohesive surgical team 
 
Orthopaedic Oncology Surgery: University of Toronto- July 2015 
Two-week elective in Mount Sinai Hospital with Dr. Peter Ferguson 
Description: 
• Clinical elective including direct patient contact in clinical settings (in and out-
patients) 
• Operating room privileges observing and participating in approximately 20 cases 
• Attended all resident teaching sessions, tumor board meetings with multi-
disciplinary team, on-call, and grand-rounds 
• Worked alongside final-year residents, fellows, and other visiting elective medical 
students in clinic and operating rooms 
• Participated in the operating rooms and out-patient clinics of Dr. Jay Wunder 
extensively during the two-week elective period 
• Further development of Orthopaedic history taking and physical exam skills as well 
as obtaining more knowledge in establishing working differential diagnoses 
• Further knowledge into the potential treatment options of various Orthopaedic 
injuries, congenital skeletal defects, and reconstructive procedures 
• Development of the communication skills required to work in a cohesive surgical team 
 
Pediatric Orthopaedic Surgery: McMaster University- July 2015  
Two-week elective in McMaster University Medical Centre with Dr. Paul Missiuna 
Description: 




• Operating room privileges observing and participating in approximately 15 cases  
• Attended all resident teaching sessions, on-call, and grand-rounds 
• Worked alongside final-year residents, fellows, and other visiting elective medical 
students 
• Participated in the operating rooms and out-patient clinics of Dr. Devin Peterson, Dr. 
Jung Mah, Dr. Rick Ogilvie extensively as well as participated in the clinics of Dr. 
Bradley Petrisor, and Dr. Sarah Burrow 
• Further development of Orthopaedic history taking and physical exam skills as well 
as obtaining more knowledge in establishing working differential diagnoses 
• Further knowledge into the potential treatment options of various Orthopaedic 
injuries, congenital skeletal defects, and reconstructive procedures 
• Development of the communication skills required to work in a cohesive surgical team 
 
Community Orthopaedic Surgery: Schulich School of Medicine and Dentistry- 
Western University, SWOMEN program- June-July 2015  
Two-week elective through the Southwestern Ontario Medical Education Network with 
Dr. John Turnbull  
Description: 
• Operating Room privileges participating in approximately 25 cases  
• Clinic privileges and further involvement as I was the only student 
• Further Rural medicine experience and understanding of the Ontario Health System  
• Extensive involvement in the operating room with Dr. John Turnbull, Dr. Hans Hundt, 
Dr. Jonathan Stone, and Dr. Zaheer Kukkadi as surgical assist 
• Further development of Orthopaedic history taking and physical exam skills as well 
as obtaining more knowledge in establishing working differential diagnoses 
• Further knowledge into the potential treatment options of various Orthopaedic 
injuries, congenital skeletal defects, and reconstructive procedures 
• Development of the communication skills required to work in a cohesive surgical team 
 
Orthopaedic Research: Western University: January-March 2014  
Six weeks in the Fowler Kennedy Clinic with Dr. Kevin Willits 
Description:  
• Completed clinically relevant retrospective review looking at bone healing with 
computed tomography following medial opening wedge high tibial osteotomy 
• Attended clinics at Fowler Kennedy 
• Attended operating room cases relevant to the research as well as supplemental 




Orthopaedic Surgery Observership: Chatham-Kent Health Alliance June–August 
2013 
Ten weeks of Orthopaedic Surgery observership in Chatham, Ontario under Dr. Hans 
Hundt.  
Description:  
• Participated in daily routines observing Dr. Hans Hundt and Dr. John Turnbull.   
• Participated in surgical rounds for in-patients 
• Took part in weekly clinics and ambulatory care 
• Observed and assisted with over 140 Orthopaedic surgical cases ranging from total 
joint arthroplasty to arthroscopy 
• Attended on-call with Dr. Hundt  
• Gained knowledge of basic pathological, physiological, and natural disease history 
principles of common Orthopaedic conditions and injuries 
 
Extracurricular Activities & Involvement 
 
Peer-led Tutor: Royal College of Surgeons Ireland 2015-2016 
Description:  
• Tutorials in Orthopaedic Physical Examination.  
• Small group teaching tutorials for students beginning their clinical learning.  
President of the Royal College of Surgeons Orthopaedic Society: 2015-2016  
Description: 400+ member society focused on increasing the interest and teaching the 
basic principles of Orthopaedic surgery.  
• Further development of previous events such as Orthopaedic tool representative 
talks 
• Development of events to engage students and peak interest in the field of 
Orthopaedic Surgery 
• Organization of case presentations and Journal Clubs 
• Provision of peer-led teaching tutorials on Orthopaedic Physical Examination 
• Provided assistance to younger students with preparation for summer Orthopaedic 
electives. 
• Organized and successfully completed an introduction to plaster casting event  




• Event coordinator responsible for planning and organization of educational and 
entertaining society events for members 
• Provided students further knowledge into the profession of Orthopaedic Surgery 
• Branding development and social-media management for the society 
	
	
 
 
 
